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Bacteriophage tails, despite differences in their morphology, all play a key role in host 
recognition and DNA injection. It is widely believed that the tail, especially the baseplate / tail 
tip, has to undergo conformational change and protein rearrangement during infection. This 
change has been observed in both the long, contractile tail of T4 and the short tail of T7. In 
contrast, little is known about this aspect of the long, non-contractile tail of bacteriophage λ. 
Four proteins are involved in the λ tail tip assembly. I present evidence that gpJ, gpI, gpL and 
gpK are components of the tail tip complex. My results also suggest that there may be about 
three copies of gpI and three copies of gpL involved in the λ tail assembly. In addition, I have 
successfully purified gpL, which contains eight cysteines. My results show that when the 
conserved cysteine at position 173, 182 or 205 is mutated to serine, the mutant protein is 
defective in tail assembly. However, the C212S mutant accumulates a small amount of tail. 
Further analysis of this mutant indicates that C212 may have roles in both tail assembly and 
DNA injection. 
 
gpK is required for λ tail assembly, but is not detected in the mature virion. Two different amber 
mutations were introduced into gene K. Neither of these mutants is able to complement in vivo. 
 iii
However, the short amber fragment is unable to assemble λ tail whereas phage-like particles with 
little infectivity accumulate in the long amber fragment lysate. The results indicate that the 
function of gene K can be bypassed to some extent in the Kam768 mutant, but not in the Kam6 
mutant. 
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1.0 INTRODUCTION 
Bacteriophages are the most abundant life form on the planet (Wommack and Colwell, 2000; 
Hendrix, 2003). They are widely distributed in the world, including soils, hot springs, deep seas 
and so on. Due to their relatively simple structures, phages have been used as model systems to 
learn how proteins interact with each other to assemble macromolecular structures. 
 
The bacteriophage lambda has been proven to be a good model system to study the regulation of 
the assembly of complex structures. It has an icosahedral head and a long, flexible, non-
contractile tail (Kellenberger, 1961; Kemp et al., 1968). In tailed phages, the tail carries out an 
important role in host recognition and DNA injection. It is likely that the tail, especially the tail 
tip / baseplate, needs to undergo conformational change and protein rearrangement in order to 
make channels for the translocation of viral DNA into the cytoplasm. This change has been 
reported in the long, contractile tail of phage T4 and the short tail of phage T7 (Simon and 
Anderson, 1967; Crowther et al., 1977; Molineux, 2001; Kemp et al., 2005). In terms of the 
flexible, non-contractile tail of bacteriophage lambda, the tail assembly pathway has been 
established for more than thirty years (Katsura and Kuhl, 1975). However, little is known about 
the function and positions of the tail proteins, neither do we know much about the molecular 
machine of DNA injection. This thesis is aimed to learn some themes of the lambda tail tip, 
which may help understand the general mechanism of lambda DNA injection.  
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1.1 THE TAIL OF BACTERIOPHAGES 
The tailed bacteriophages are generally believed to be the most diversified of all virus groups. 
Most of them have an icosahedral head and a tail that may vary in structure among different 
phages. Based upon the morphology of the tail, bacteriophages can be divided into three groups: 
(1) myoviridae: a family of phage with long, non-flexible, contractile tails like T4; (2) 
siphoviridae: a family of phage with long, flexible, non-contractile tails like λ; (3) podoviridae: a 
family of phage with short, non-contractile tails like T7 (Figure1.1) (Maniloff and Ackermann, 
1998). The difference in the structure of the tail among different phage groups may reflect the 
different mechanisms they adopted to inject viral DNA during infection.  
1.1.1 Tail structure 
Although most of the tailed bacteriophages have a similar morphology of the head, the 
morphology of the tail differs greatly among different groups of bacteriophages (Casjens and 
Hendrix, 1988) (Figure 1.1). In spite of the difference in the morphology of the tail, all the 
bacteriophage tails carry out a key role in phage adsorption to the host cell and DNA injection 
during infection. Therefore, it is not surprising for bacteriophages to share some common 
features of the tail, even though the same substructure may be different in morphology. The 
common features of the bacteriophage tail will be listed below. 
 
Tail fiber: The tail fiber is located at the distal end of the tail. It is the most important 
substructure in the process of attachment of phage to the host cell. The structure of tail fibers 
varies among different types of phages. The bacteriophage T4 has six tail fibers that are  
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Figure 1.1 Schematic diagram of five bacteriophages (Casjens and Hendrix, 1988; Xu, 2001). 
 
Although the morphology of the head is quite similar among tailed bacteriophages, the 
morphology of the tail is dramatically different. The myoviridae phage T4, for instance, 
possesses a long, rigid, contractile tail whereas the siphoviridae phage λ has a long, flexible, 
non-contractile tail. Phages T3/T7, P22 and φ29 have short tails and belong to the podoviridae 
family. 
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podoviridae 
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responsible for binding to the host cells (Kellenberger et al., 1965; Simon and Anderson, 1967; 
Simon and Anderson, 1967). The well-studied bacteriophage λ has a single, thin tail fiber which 
interacts with the LamB host receptor (Randall-Hazelbauer and Schwartz, 1973; Szmelcman and 
Hofnung, 1975) and determines the host specificity during infection (Dove, 1966; Mount et al., 
1968; Buchwald and Siminovitch, 1969).  In the short-tailed bacteriophages, the tail fiber may be 
also called spikes, thick fibers, appendages or tail proteins. 
 
Tail tip / Baseplate: The tail tip (λ like) or baseplate (T4 like) is where the tail fiber is bound. It 
is a multi-protein structure in the tail with various shapes and complexity in different phages and 
plays an important role in host recognition and DNA injection. It may undergo dramatic 
conformational change and protein rearrangement in order to allow the passage of phage DNA 
into the cell. The T4 baseplate is a well-characterized multiprotein machine which carries out an 
important role during infection. It has a dome-shaped structure with a central spike formed by the 
gp5-gp27 (gp for gene product) complex (Kanamaru et al., 2002; Kostyuchenko et al., 2003). 
The positions and stoichiometry of individual proteins have been determined by fitting X-ray 
structures into the cryo-EM density (Rossmann et al., 2001; Rossmann et al., 2004).  
 
In terms of bacteriophage λ, four proteins are known to be required for the tail tip formation. The 
order of interactions among these proteins was determined by in vitro complementation assays 
(Katsura and Kuhl, 1975; Katsura, 1976). However, little is known about the structure and 
composition of the tail tip, probably due to the small size of the tail tip and the difficulty in the 
expression and purification of these proteins as will be shown in the following chapters. 
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The short-tailed bacteriophages like P22 and T7 have a single, central structure surrounded by a 
baseplate or collar. The shape of this structure appears greatly variable among them. In addition 
to the function of the baseplate proteins, they may also behave like head and tail completion 
proteins. 
 
Side tail fiber (stf): In addition to the tail fiber, many phages also have several long, L or Z 
shaped side tail fibers attached to the tail tip / baseplate. They help the adsorption of the 
bacteriophages to the host cell surface and increase host specificity during infection. In some 
phages, such as T4, the long fibers are absolutely required infection, possibly because they 
trigger essential conformational rearrangement of the baseplate (Makhov et al., 1993). In other 
phages, including λ and T5, the phage is still infective in the absence of the fibers, although the 
kinetics of adsorption to the cell is slower (Heller and Braun, 1979; Hendrix and Duda, 1992). In 
both T4 and λ, the assembly of the side tail fiber requires a chaperone (Tfa in λ and gp38 in T4). 
The chaperone is absent in the mature structure of the side tail fiber of phage T4, but it is present 
in the final structure of the side tail fiber of phage λ (Hendrix and Duda, 1992). It has been 
reported that the λ Tfa can functionally substitute for the T4 gp38 in vivo (Montag and Henning, 
1987). The four side tail fibers have been missing in the common laboratory stain of 
bacteriophage λ (λ PaPa) since 1950’s due to a single base deletion in the gene encoding side tail 
fiber. Compared to λ PaPa, Ur-λ, the original isolate with side tail fibers adsorbs to host cells 
more quickly (Hendrix and Duda, 1992). 
 
Tail shaft: Bacteriophages with long tails have a structure called the tail shaft formed on the tail 
tip / baseplate, which is likely to be a passive conduit for phage DNA due to the lack of evidence 
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that it actively participates in propelling phage genome into the cell (Casjens and Hendrix, 1988). 
There are generally two types of tail shaft: rigid, contractile ones and flexible, non-contractile 
ones. In the myoviridae family of T4, the tail shaft consists of an internal cylindrical tube 
assembled from gp19, and an outer, contractile sheath which is composed of 138 molecules of 
gp18 arranged into 23 hexameric rings (King, 1968; Amos and Klug, 1975; Moody and 
Makowski, 1981; Leiman et al., 2004). It is the tail sheath that contracts dramatically during 
DNA injection. The tail shaft of the siphoviridae phage λ contains 32 stacked rings of six gpV 
subunits each (Buchwald et al., 1970; Casjens and Hendrix, 1974; Katsura, 1983). Despite the 
difference in the morphology of the tail shaft of phage T4 and λ, both of them use the tape 
measure protein to determine the tail length. The detailed mechanism about how the tape 
measure protein determines the tail length is not well understood. It is interesting that the tails of 
phages which are even not very closely related can have an identical appearance except for the 
different tail lengths (King, 1968; Youderian, 1978; King, 1980; Katsura and Hendrix, 1984). 
The long tails may allow phages to search for suitable receptors in the surrounding environment 
more efficiently (Schwartz, 1976). 
 
Tail completion protein: At the head-proximal end of the tail are the tail completion proteins 
which stop the polymerization of the major tail protein and probably create a site for the 
attachment of head. In bacteriophage λ, the terminator protein gpU forms a hexameric ring 
which caps the tail shaft when it reaches the correct length, and the tail is activated by the 
addition of gpZ (Casjens and Hendrix, 1974; Katsura, 1976; Edmonds et al., 2007). In 
bacteriophage T4, two proteins, gjp3 and gp15, are required for the completion of tail assembly. 
Each of them forms a hexameric ring, which are required for the termination of the tail tube 
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elongation (gp3) and formation of a connector which enables the tail to bind to the head (gp15) 
(King, 1968; Vianelli et al., 2000; Zhao et al., 2003). In terms of the short- tailed phages, the tail 
is assembled directly on the head and it is not useful to distinguish between the head completion 
proteins and the tail completion proteins.  
1.1.2 Structural movements and DNA injection 
In spite of the dramatic differences in the morphology, all the tails of bacteriophages play a key 
role in host recognition and DNA injection. The course of infection begins with the attachment 
of phage to the host cell surface with the help of the tail fiber, followed by an intricate process to 
inject phage genome into the cytoplasm. The injection of DNA is generally accompanied by 
dramatic conformational change and protein rearrangement.  
 
In bacteriophage T4, the baseplate has a hexagonal shape in the mature virion. Upon attachment 
to the host cells, the T4 baseplate undergoes extensive protein rearrangement which results in a 
star shape (Simon and Anderson, 1967; Crowther et al., 1977). For instance, upon the completion 
of the hexagonal-to-star conformational transition, gp11, a component of the wedge, rotates by 
approximately 100° and interacts with the long instead of the short tail fiber (Leiman et al., 2004; 
Arisaka, 2005) (Figure 1.2). The hexagonal-to-star conformational transition triggers sheath 
contraction, which is due to the substantial rearrangement of the domains within the sheath 
protein (Moody, 1973; Leiman et al., 2004). The sheath contraction leads to the extension of the 
tail tube beneath the baseplate (Leiman et al., 2004). With the help of the tail lysozyme, gp5, the 
tail tube penetrates through the cell envelope (Kanamaru et al., 2002), followed by the release of 
the phage DNA into the cytoplasm through the tube (Simon and Anderson, 1967). 
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Figure 1.2 Protein rearrangements during the hexagonal-to-star change of the T4 baseplate 
(Arisaka, 2005). 
 
In the mature virion, gp11 (as indicated by arrows in (a) and (b)) is bound to the kink region of 
the short tail fiber (STF) gp12.  After completion of the conformational change, it moves to 
interact with the long tail fiber (LTF) gp34. Instead of being accommodated beneath the 
baseplate in the mature virion, the short tail fibers extrude downward with their tips binding 
tightly to the cell surface after the conformational change. The numbers in the figure indicate the 
corresponding gene products. 
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(b) 
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The podoviridae phage T7 has a short, non-contractile tail. Unlike most other tailed 
bacteriophages whose tail assembly is independent of head assembly, the stubby tail of T7 forms 
directly on the DNA-filled head (Studier, 1972; Roeder and Sadowski, 1977; Matsuo-Kato et al., 
1981). The 23-nm-long tail is too short to span the E. coli cell envelope. In contrast to the well-
studied contractile tail of T4, five virion proteins of T7 (three internal core proteins: gp14, gp15 
and gp16, the head protein gp6.7, and the tail protein gp7.3) are ejected into the cytoplasm at the 
initiation of infection, which functionally endows T7 with an extensible tail and allows the 
translocation of phage genome into the cell (Molineux, 2001; Kemp et al., 2005; Serwer et al., 
2008). The ejected virion proteins need to undergo dramatic conformational change at the 
initiation of infection (Moak and Molineux, 2000; Molineux, 2001; Kemp et al., 2005). The three 
internal core proteins, gp14, gp15 and gp16, must disaggregate from the structure and almost 
completely unfold in order to pass through the head-tail connector (Moak and Molineux, 2000; 
Molineux, 2001; Kemp et al., 2005). The internal core protein of T7, gp16, has  transglycosylase 
activity and facilitates infection (Moak and Molineux, 2000). The details of how the proteins 
change their conformation in order to be ejected and how they interact with each other to form 
the extended tail remain unknown. 
 
Little is known about how the siphoviridae phage λ translocates its viral DNA into the host cell. 
This is probably due to the lack of detailed information about the structures of the tail and the 
individual proteins. It has been inferred from previous experiments that the tail fiber protein, gpJ, 
probably moves during infection (Roessner and Ihler, 1984) and gpH* may exit the tail and enter 
into the cell with the phage genome during DNA injection (Roa, 1981).  
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1.1.3 Cysteine residues in the bacteriophage tail proteins 
In prokaryotes, many proteins contain cysteine residues, some of which are essential for protein 
folding (Gilbert, 1990). The cytoplasm of bacteria is widely believed to be unfavorable for 
disulfide bond formation due to its reducing environment. In spite of this, there has been 
evidence that some cysteine residues in the bacteriophage tail proteins carry out important roles 
in protein formation or tail assembly which may involve the transient formation of disulfide 
bonds. 
 
In the baseplate of bacteriophage T4, each of the six wedge complexes is composed of seven 
proteins, including three copies of gp10 (Zhao et al., 2000). Gp10 has five cysteines, three of 
which are involved in disulfide bond formation (Zhao et al., 2000). Two molecules of gp10 in 
the complex participate in a disulfide bond formation while the remaining one does not (Zhao et 
al., 2000). Although the detailed information about how this asymmetric structure is formed by 
gp10 and what the role of the disulfide bond is in tail assembly remains an open question, it may 
be safe to say that some or all of the five cysteines in gp10 may have a key role in the wedge 
formation. 
 
The Salmonella phage P22 has a short tail. The tailspike protein of P22 has 8 cysteines among its 
666 amino acids (Sauer et al., 1982). No disulfide bonds have been found in the native state of 
the tailspike protein (Sargent et al., 1988; Steinbacher et al., 1994). However, there is a transient 
interchain disulfide bond formation in the protrimer intermediates which is required for the 
correct folding and assembly of the tailspike  (Sather and King, 1994; Robinson and King, 1997). 
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The λ tail assembly is controlled by at least eleven proteins (Campbell, 1961; Parkinson, 1968), 
some of which contain several cysteine residues in their protein sequences.  For example, gpJ has 
11 cysteines among its 1132 amino acids whereas gpL contains 8 cystienes among its 232 amino 
acids. Some of the cysteine residues are highly conserved among the homologs and may carry 
out important roles in protein formation, tail assembly or DNA injection. The cysteine residues 
in gpL will be investigated in this study. 
1.2 THE BACTERIOPHAGE LAMBDA 
The bacteriophage λ has an icosaheral head with 55nm in diameter and a long, non-contractile 
tail that is 150 nm long excluding the 23-nm tail fiber (Kellenberger, 1961; Kemp et al., 1968; 
Katsura, 1983) (Figure 1.3). The morphogenesis of λ is controlled by a number of genes located 
in the left arm of the phage chromosome (Campbell, 1961; Weigle, 1966; Parkinson, 1968). Due 
to the large number of mutants available and the vast accumulation of knowledge about this 
phage, the λ tail has been recognized as a good model system for the study of biological 
assemblies. The following will give a summary of the λ growth cycle and some knowledge 
concerning the λ tail. 
1.2.1 Life cycle 
λ is a temperate phage and can follow two different life cycles (Figure 1.4). At the beginning of 
the life cycle, λ binds to its host receptor, LamB, by its tail fiber and forms a reversible complex 
(Randall-Hazelbauer and Schwartz, 1973; Szmelcman and Hofnung, 1975). Subsequently, an  
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Figure 1.3 The morphology of bacteriophage lambda. (a). Negatively stained bacteriophage Ur-
λ (Courtesy of Duda, R.L.). (b). Schematic diagram of the bacteriophage λ and a disk at end 
view (Katsura, 1983; Xu, 2001). The bacteriophage λ has an icosahedral head 55 nm in diameter 
and a long, non-contractile tail. The tail is composed of the 135-nm-long tail shaft and 38-nm-
long tail tip. The tail shaft is comprised of 32 hexameric rings. 
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Figure 1.4 The main steps of the life cycle of bacteriophage lambda (Redrawn from (Arber, 
1983) with modifications). λ is a temperate phage and can follow two different life cycles. In the 
lytic cycle, λ multiplies inside the bacteria. Progeny phages are released after cell lysis. In the 
lysogenic cycle, the phage genome is incorporated into the host cell chromosome and replicated 
in a passive way. 
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inactivation step makes the phage-LamB complex irreversible, followed by a ‘delay time’ before 
triggering the injection of the linear double-stranded phage DNA into the cytoplasm (Roa and 
Scandella, 1976). This pause can be shortened by increasing the temperature, with a maximum at 
37℃(Lof et al., 2007). When the temperature is at 4℃, phage DNA will not be injected at all 
(Novick and Baldeschwieler, 1988; Lof et al., 2007). The general mechanism of DNA injection 
is not well understood. However, it is possible hat the tail undergoes conformational change and 
protein rearrangement in order to inject the viral DNA.  
 
Early genes, which are mainly responsible for the regulation of phage development, are 
expressed a little after DNA injection. Subsequently, either of the following two pathways may 
occur: (1) In the lytic cycle, the phage multiplies inside the bacteria. A phage-encoded enzyme 
called transglycosylase then lyses the host cell, leading to the liberation of about one hundred 
progeny phages which are synthesized within 50 minutes at 37℃; (2) In the lysogenic cycle, the 
phage DNA is incorporated into the host cell chromosome at a characteristic site and replicated 
in a passive way (Hershey, 1983). Almost all of the phage genes are repressed in the lysogenic 
cycle and therefore no progeny phages are produced. The phage DNA at this stage (prophage) 
can enter the lytic cycle through induction, a process in which the phage genes are derepressed 
and phage DNA is excised from the host chromosome. The lysogenic (prophage-containing) 
cells can be induced at high frequency by exposure to DNA-damaging agents such as ultraviolet 
light. The signal which allows prophage to undergo this transition “spontaneously” at low 
frequency in vivo is not clear. The early genes determine which of the above pathways the phage 
will take (Herskowitz and Hagen, 1980).  
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The late genes, including the phage morphogenetic genes and lysis genes, are expressed in the 
lytic cycle a little while after infection or induction until cell lysis. The  morphogenetic proteins 
of  λ are transcribed from the same operon and the functional half-life of the mRNA for each 
gene is not significantly different, but the morphogenetic proteins are synthesized in widely 
different molar amounts (Murialdo and Siminovitch, 1972; Ray and Pearson, 1974; Sampson et 
al., 1988). This is probably due to the various rates of the initiation of translation (Sampson et al., 
1988). Lambda head and tail assemble independently from the morphogenetic proteins, which 
subsequently join together to form a biologically active phage (Weigle, 1966; Weigle, 1968). 
The products of lysis genes cause host cell lysis, which leads to the release of progeny phages. 
1.2.2 Lambda tail assembly pathway 
The assembly of λ tail starts from the tail fiber, located at the distal end of the tail, and proceeds 
to the proximal end of the tail. At least eleven genes are involved in the tail assembly pathway 
(Campbell, 1961; Parkinson, 1968). The assembly pathway was established by a series of in vitro 
complementation assays in 1970s  (Katsura and Kuhl, 1975; Katsura, 1976) and was modified 
recently based on new data (Xu, 2001) (Figure 1.5). The λ tail assembly pathway can be divided 
into three steps and the following will give a summary of each step.  
 
Formation of the initiator: The formation of the initiator begins with three copies of gpJ to 
form a [15S]I particle, followed by the sequential addition of gpI, gpL and gpK to form a [15S]II 
particle (Katsura and Kuhl, 1975; Katsura, 1976). Before joining the [15S]II complex to form a 
complex, gpH and its chaperones, gpG and gpGT, form a subassembly (Xu, 2001). Finally, gpM 
is added to stabilize the 25S complex (Katsura and Kuhl, 1975). 
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Figure 1.5 The tail assembly pathway of bacteriophage lambda (Katsura and Kuhl, 1975; Xu, 
2001). 
 
The primary assembly pathway has been worked out by a series of in vitro complementation 
assays (Katsura and Kuhl, 1975). A small modification has been made by Xu (2001) who 
showed that gpG and gpGT are chaperones for gpH, and the three proteins form a subassembly 
before joining the 15S complex. It is not clear, however, whether or not a few molecules of the 
major tail protein, gpV, might be involved in the formation of the initiator. 
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Polymerization of the major tail protein: After formation of the initiator, the major tail protein 
gpV begins to polymerize upon the initiator. In the absence of the initiator or of something that 
imitates the initiator, the major tail protein exists in a monomer-dimer equilibrium and can not 
assemble into tail-related structures (Katsura and Tsugita, 1977).  
 
Termination and maturation: The polymerization of the major tail protein gpV pauses for a 
while when the tail reaches the correct length which is determined by the tape measure protein 
gpH (Katsura and Hendrix, 1984). At this point, gpU, the terminator protein which can form 
hexameric rings, joins tail assembly and stops polymerization of gpV. In the absence of gpU, 
gpV continues to polymerize which results in polytails (Mount et al., 1968; Katsura, 1976). At 
about the same time, a peptide of about 10 kDa is cleaved off from the tape measure protein gpH 
(Murialdo and Siminovitch, 1972; Tsui and Hendrix, 1983). At this stage, the tail looks normal, 
but it is defective. After addition of gpZ, the tail is activated and is ready to join the head to form 
a biologically active phage (Katsura and Kuhl, 1975).  
 
The picture of λ tail assembly pathway has been known for more than thirty years. However, it 
leaves many questions unanswered. For instance, the function and exact positions of most 
proteins in the structure remain unknown. Besides, we know little about the molecular machine 
of DNA injection.  
1.2.3 Function of the individual tail proteins 
The λ tail assembly is under the control of at least eleven phage proteins. Thanks to the various 
mutants available and the in vitro complementation assay, the order of interactions among these 
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proteins has been established (Katsura and Kuhl, 1975). However, little is known about the 
structure and function of most of the tail proteins. The following is a summary of the available 
information for λ tail proteins.    
 
gpJ: gpJ, the tail fiber protein of phage λ, is the first protein involved in the tail assembly.  Three 
copies of gpJ comprise the single, thin tail fiber, which is located at the distal end of the tail 
(Casjens and Hendrix, 1974). The size of the fiber only accounts for a minority of the mass of the 
three molecules of gpJ, so most of the mass of the gpJ subunits must be in the conical tail tip 
(Roessner and Ihler, 1987). It interacts with the host cell receptor and determines host specificity 
during infection (Dove, 1966; Mount et al., 1968; Buchwald and Siminovitch, 1969). It has been 
reported that the C-terminal part of gpJ is responsible for the interaction with the LamB host 
receptor (Randall-Hazelbauer and Schwartz, 1973; Szmelcman and Hofnung, 1975; Wang et al., 
2000). 
 
gpG and gpGT: gpG and gpGT are related by a programmed -1 translational frameshift (Levin 
et al., 1993). They are chaperones for the tape measure protein, gpH (Xu, 2001). Although both 
proteins interact with gpH, only the T part of gpGT has interactions with the major tail protein, 
gpV (Xu, 2001). Neither gpG nor gpGT is present in the mature tail (Levin et al., 1993). 
 
gpH: The tape measure protein, gpH, is the one that determines the tail length of phage λ 
(Katsura and Hendrix, 1984) and may be involved in DNA injection (Scandella and Arber, 1976; 
Katsura, 1983). Shorter-tailed phage particles can be obtained by in-frame deletion of gpH 
(Katsura and Hendrix, 1984). About six copies of gpH are present in each phage (Casjens and 
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Hendrix, 1974). The 90-kDa gpH is processed to a 78-kDa product, gpH*, during tail assembly 
(Hendrix and Casjens, 1974). It is gpH*, but not gpH, that is present in the mature virion. 
 
gpV: gpV is the major tail protein which forms the tail shaft. About one-third of the major tail 
protein near the C-terminus can be removed and phage particles with the short version of gpV 
can maintain its total shape and infectivity (Katsura, 1981). The removable C-terminal portion of 
gpV has been identified as an Ig-like domain (Fraser et al., 2006). Such domains are found at the 
C-terminus of some but not all major structural proteins of tailed phages. Under certain 
conditions, gpV may polymerize into polytails (a structure of undertermined tail length with tail 
tip) or polytubes (a structure of undertermned tail length without the tail tip) (Katsura, 1976).  
 
gpU: gpU, the terminator protein, is located at the head-proximal end of the tail and serves as an 
interface for attachment of the head to the tail (Katsura and Tsugita, 1977). In the absence of 
Mg(II), gpU exists as a globular monomer, but it changes to ring-like hexamer upon treatment 
with 20 mM  Mg(II) (Katsura and Tsugita, 1977). The NMR structure of the monomeric form 
reveals that gpU is a single domain protein possessing a mixed α/β motif and several dynamic 
loops at the periphery (Edmonds et al., 2007). 
 
gpI, gpL, gpK, gpM and gpZ: The function of these proteins remains unknown. We do know, 
however, what part of the assembly pathway they act in and we know the Z- phenotype. The Z--
lysate contains phage-like particles with little infectivity (Katsura and Kuhl, 1975). gpI, gpL and 
gpK will be investigated in this study.  
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1.2.4 Morphogenetic genes and λ tail assembly 
Gene order: Despite the fact that bacteriophages show dramatic differences in morphology, it is 
interesting to note that the gene order of bacteriophages in their genomes seems to be conserved 
among different families, particularly for the genes encoding structural components of the 
virions (Casjens and Henrix, 1988). It is not clear if this conservation of gene order will help us 
understand the details of the phage assembly process. But, there may be evolutionarily 
advantages since this linkage may allow gene modules to be evolutionally exchanged among 
phages and minimizes the formation of defective hybrids (Stahl and Murray, 1966; Casjens and 
Hendrix, 1974; Echols and Murialdo, 1978; Campbell, 1983).  λ is a good example for the study 
of gene order. Figure 1.6 shows that the head and tail genes of λ are arranged in two non-
overlapping, adjacent clusters. In contrast to the order in which the gene products are added to 
the tail during assembly, transcription of the tail genes of λ proceeds in the reverse order.  
 
Relative expression rates of the morphogenetic genes: It has been known in bacteriophages 
that the relative expression rates of the morphogenetic genes generally reflect the amounts of the 
corresponding gene products needed to assemble phage particles. In λ, the structural genes lie 
within a single operon and the functional half-life of the mRNA for each gene differs less than 
two-fold, but the morphogenetic proteins are synthesized in widely different molar amounts 
(Murialdo and Siminovitch, 1972; Ray and Pearson, 1974; Sampson et al., 1988) (Figure 1.6).  
This ratio among structural proteins may be important in controlling the tail assembly. Deviation 
from the normal protein ratios may cause problems in assembly. One instance is the λ tail 
terminator protein gpU, which is made in approximately 50-fold over the amount found in the  
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Figure 1.6 The morphogenetic genes of bacteriophage λ (Redrawn from (Casjens and Hendrix, 
1988) with modifications). 
 
The physical size and positions of all the morphogenetic genes of bacteriophage λ are shown 
(with a scale in kbp). All the morphogenetic genes lie within a single operon. Normal 
transcription is from left to right. The schematic diagram of λ is shown above, and the positions 
of the structural proteins in the virion are indicated by arrows. gpFI is involved in DNA 
packaging and is not found in the mature virion. gpG and gpGT are chaperones for gpH and they 
are not present in the mature structure of the virion. The relative expression rate of tail genes and 
the current best estimated number of molecules of each tail protein required to construct one 
particle are shown below. 
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mature virion. In the absence of gpU, gpV continues to polymerize which results in long tails 
with little infectivity. Thus, it may be essential to have a large amount of gpU in order to make 
sure gpU terminates the tail in time and no abnormal assembly happens. Another example is gpG 
and gpGT of λ. They are chaperones for gpH and are related by a programmed frameshift. It has 
been shown that the ratio between these two proteins is important for normal tail assembly (Xu, 
2001). Changes in the ratio of the two proteins may cause trouble in tail assembly (Xu, 2001).             
1.2.5 The tail tip of phage λ  
The λ tail tip is composed of a conical part and a short, central tail fiber. The conical part may be 
composed of three or four disks (Katsura, 1983) while the tail fiber is composed of three copies 
of gpJ. The assembly of λ tail tip is controlled by at least four proteins (gpJ, gpI, gpL and gpK). 
The order of the interactions between those proteins has been established for many years. 
However, little is known about its structure probably due to the small size of the tail tip, neither 
do we know much about the function and stoichiometry of the tail tip proteins. This study is 
aimed to understand some themes of the lambda tail tip.  
1.3 THESIS PLAN 
This study is composed of four parts: 
 
(1) The first part deals with the expression and purification of λ tail tip proteins. I first tried to 
label gpJ with a polyhistidine tag to facilitate the purification of the tail tip complex. However, 
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most of the complex is insoluble, which makes the purification impractical. Then, I tried to 
purify the individual tail tip proteins. Each target protein was labeled with three different tags. 
Several purification methods were used to purify the tail tip proteins. Protein gpL has presented 
the fewest difficulties of expression and solubility, and its purification has been the most 
successful. 
 
(2) The second part is about determination of the composition and stoichiometry of the λ tail tip 
complex. Several different techniques were used to separate and analyze the tail tip complex. 
The stoichiometry of the lambda tail tip complex was estimated by densitometry. 
 
(3) The third part is about the characterization of the cysteine residues in λ tail tip protein, gpL. 
According to the multisequence alignment, four of the cysteine residues (cysteine residues at 
positions 173, 182, 205 and 212) are highly conserved among lambda gpL homologs while the 
other four (cysteine residues at positions 12, 39, 140 and 208) are not. Each of the individual 
cysteine residues was mutated to serine or other residues. The results from the in vivo 
complementation assay show that the single amino acid substitutions at the nonconserved 
cysteines have little effect on the biological activity of the protein while the single amino acid 
substitutions at the conserved cysteine residues abolish the in vivo activity of the protein. This 
implies that the conserved cysteines may be important in protein folding or tail assembly or for 
functioning of the assembled tail. A series of assays were carried out to further investigate the 
role of the conserved cysteine residues of gpL. 
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(4) The last part is concerned with λ tail tip protein, gpK. gpK is a mystery because it is required 
for tail assembly, but it has not been found in the mature virion. Two different amber mutations 
were constructed into gene K. One is at the beginning of the gene while the other is near the end 
of the gene. The in vivo complementation assay indicates that both of them have little 
complementation activity. These mutants were further characterized by in vitro assays. 
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2.0 MATERIALS AND METHODS 
2.1 BACTERIAL STRAINS 
(1) BL21(DE3)-Δtail 
F- dcm ompT hsdSB(rB- mB-) gal λ(DE3)-Δtail. This strain contains λ prophage, DE3, with the tail 
portion of DE3 being knocked out by deletion. It was used as the host strain for most protein 
expression experiments and spot complementation assays.  
Source: Hendrix lab collection; constructed by J. Xu (Xu, 2001). 
 
(2) BL21 StarTM(DE3) 
F- dcm ompT hsdSB(rB- mB-) gal rne131 λ(DE3). This strain carries a mutation in the gene 
encoding RNaseE (rne131) and was used as the host strain for pLC3 based plasmids.  
Source: Invitrogen. 
 
(3) RosettaTM 2 
F- dcm ompT hsdSB(rB- mB-) gal pRARE2 (CamR). This strain provides tRNAs for 7 rare codons 
(AGA, AGG, AUA, CUA, GGA, CCC, and CGG) and enhances the expression of proteins 
which contain codons rarely used in E. coli.  
Source: Novagen. 
 30
(4) XL1-Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ proAB lacIqZ△M15 Tn10 (Tetr)] was 
used as the host strain for the nicked dsDNA from site-directed mutagenesis.  
Source: Stratagene. 
 
(5) DH10B 
F− mcrA Δ(mrr-hsdRMS-mcrBC) 80dlacZΔM15 ΔlacX74 deoR recA1 araD139 Δ(ara leu)7697 
galU galK rpsL endA1 nupG.  
Source: Hendrix lab collection. 
 
(6) Ymel 
supF (suppressor strain) was used in the plaque assay and the phage plate stock experiments. 
Besides, it was also used in the experiment designed to precipitate lambda tail and its assembly 
intermediates.  
Source: Hendrix lab collection. 
 
(7) C600 
supE (suppressor strain) was used to select Sam7 revertants.  
Source: Hendrix lab collection. 
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(8) CR63 
F+, LAM-, serU60(AS), lamB63 was used as the negative control for the experiment using E. 
coli cells to precipitate lambda tail and its assembly intermediates.  
Source: Hendrix lab collection. 
 
(9) Lysogens for making phage stocks 
594 (λSam7cI857) 
C600 (λJam27Sam7cI857) 
C600 (λIam838Sam7cI857) 
C600 (λLam756Sam7cI857) 
C600 (λKam768Sam7cI857) 
Source: Hendrix lab collection. 
 
(10) Lysogen used for λ head preparation 
594 (λVam750Sam7cI857)  
Source: Hendrix lab collection. 
 
(11) Lysogens for making concentrated tail-defective lysates 
594 (λJam442Sam7cI857) 
594 (λIam838Sam7cI857) 
594 (λLam756Sam7cI857) 
594 (λKam768Sam7cI857) 
Source: Hendrix lab collection. 
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2.2 MEDIA AND BUFFERS 
2.2.1 Media 
(1) Luria Broth (LB) 
1% (w/v) Bacto tryptone, 0.5% (w/v) Bacto yeast extract and 0.5% NaCl in ddH2O. Antibiotics 
were added at 50 μg/ml for ampicillin, 25 μg/ml for chloramphenicol and 25 μg/ml for 
kanamycin when needed. 0.4% (w/v) maltose or glucose was added to induce or inhibit phage 
receptor expression in the host when necessary. 
 
(2) LB agar 
Same ingredients as LB plus 1.5% (w/v) Bacto agar. 
 
(3) Soft agar 
Same ingredients as LB plus 0.7% (w/v) Bacto agar. 
 
(4) 10X M9A medium (use 1X) (Katsura and Kuhl, 1975) 
10.54% Na2HPO4·7H2O, 3% KH2PO4, 0.5% NaCl, 1% NH4Cl, 4% glucose, 0.25% 
MgSO4·7H2O, 0.015% CaCl2·2H2O and 10% Casamino acids (Difco) in ddH2O. 
 
(5) M9-MC medium 
1X M9 salts, 0.4% (w/v) glucose, 1 mM MgSO4, 0.1 mM CaCl2 and 1% MC medium (same 
ingredients as Difco methionine assay medium except that no cysteine was added in the MC 
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medium) in ddH2O. Appropriate antibiotics were added to 50 μg/ml for ampicillin, 25 μg/ml for 
chloramphenicol and 25 μg/ml for kanamycin when needed. 
 
(6) 10X M9 salts (use 1X) 
13.3% Na2HPO4·7H2O, 3% KH2PO4, 0.5% NaCl, 1% NH4Cl in ddH2O. 
 
(7) KG 
1X M9 salts, 5 mM MgSO4, 1.5% casamino acids, 0.2% glucose in ddH2O. 
2.2.2 Buffers 
(1) λ dil 
10 mM Tris-HCl pH 7.4, 10 mM MgCl2 
 
(2) TKG (Duda et al., 1995) 
20 mM Tris-HCl pH 7.5, 100 mM potassium glutamate 
 
(3) Lysis buffer 
50 mM Tris-HCl pH8.0, 5 mM EDTA 
 
(4) Buffer A 
0.2 M Tris-HCl pH 8.8, 40 μg/ml DNase I 
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(5) T1/10E 
10 mM Tris-HCl pH 8.0, 0.1 mM EDTA 
 
(6) Head buffer 
50 mM Tris-HCl pH 8.0, 10 mM MgSO4, 20 mM putrescene 
 
(7) Gel electrophoresis buffer 
50XTAE 
      1 M Tris-acetate, 50 mM EDTA pH 8.0 
 
4X Lower buffer for SDS-PAGE 
      1.5 M Tris-HCl pH 8.8, 0.4% SDS 
 
4X Upper buffer for SDS-PAGE 
      0.5 M Tris-HCl pH 6.8, 0.4% SDS 
 
10X Running buffer for SDS-PAGE 
      0.25 M Tris base, 2.5 M glycine, 1% SDS 
 
4X Sample buffer for SDS-PAGE 
      0.25 M Tris-HCl pH 6.8, 40% glycerol, 20% β-mercaptoethanol, 8% SDS 
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(8) Nickel affinity column buffers (Novagen with modifications) 
1X Charging Buffer 
      50 mM NiSO4 
 
1X Binding Buffer 
      20 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9 
 
1X Wash Buffer 
      80 mM imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9 
1X Elute Buffer 
      1 M imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9 
 
1X Strip Buffer 
      100 mM EDTA, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9 
 
(9) Amylose affinity column buffers (BioLabs) 
1X Column buffer 
      20 mM Tris-HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, 1 mM azide 
 
1X Elution buffer 
      1X Column buffer plus 10 mM maltose 
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20X TEV buffer (use 1X) 
1 M Tris-HCl pH 8.0, 10 mM EDTA 
 
(10) Glutathione affinity column buffers (GE Healthcare) 
Buffer B 
      50 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.1% Triton-X100, 1 mM DTT 
 
1X PBS 
      140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 
 
1X Elution buffer 
      50 mM Tris-HCl pH 8.0, 10 mM reduced Glutathione 
 
1X Cleavage buffer for PreScission Protease 
50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, pH 7.0 at 25℃, chill before use  
 
(11) Hydroxyapatite column buffers 
1X Wash buffer 
      20 mM sodium phosphate buffer pH 7.2, 200 mM NaCl 
 
1X Elution buffer 
      0.5 M sodium phosphate buffer pH 7.2 
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(12) Co-immunoprecipitation buffer 
Co-IP buffer 
      50 mM Tris-HCl pH 8.0, 10 mM MgCl2, 100 mM NaCl  
2.3 METHODS 
2.3.1 DNA manipulation 
(1) Plasmid preparation 
The plasmids were purified using QIAGEN® plasmid miniprep kit with modifications. DH10B 
carrying the target plasmid was grown in LB with appropriate antibiotics at 37℃ overnight. 
About 3 ml of the bacteria cells were pelleted and resuspended in 250 μl Buffer P1. After 
addition of 250 μl Buffer P2 to lyse the cells, 350 μl Buffer P3 was added and mixed thoroughly 
by inverting the tubes 4-6 times. The mixture was centrifuged for 10 minutes at 13,000 RPM. 
The supernatant was applied to the QIAprep spin column by pipetting. After centrifugation at 
13,000 RPM for 1 minute, the sample in the flow-through was discarded. 500 μl Buffer PB was 
added to the column followed by centrifugation at 13,000 RPM for 1 minute. The column was 
washed by 750 μl Buffer PE and centrifuged for 1 minute. The flow-through was discarded and 
the sample was centrifuged again at 13,000 RPM for 2-4 minutes to get rid of residual PE. 
Finally, 50-100 μl T1/10E buffer was added and the sample was held at room temperature for 
about 5 minutes before it was centrifuged at 13,000 RPM for 1 minute. Table 2.1 lists all the 
plasmids and construction methods used in this study. 
 
 38
Table 2.1 Plasmids used in this study 
Name Description Source*
pGEX-6P-1 This vector contains an ampicillin resistance gene, an internal 
lacIq gene and a tac promoter. It can be used to construct N-
terminal GST fusion protein. 
3 
pGEX-6P-1-J PCR fragment of J1R and J4F was digested by BamHI and 
BsrGI. The resulting fragment was inserted into the BamHI-
BsrGI sites of pGEX-6P-1-Ltail. 
1 
pGEX-6P-1-I PCR fragment of I5F and I6R was digested by BamHI and 
EcoRI. The resulting fragment was inserted into the BamHI-
EcoRI sites of pGEX-6P-1. 
1 
pGEX-6P-1-K PCR fragment of K5F and K6R was digested by BamHI and 
EcoRI The resulting fragment was inserted into the BamHI-
EcoRI sites of pGEX-6P-1. 
1 
pGEX-6P-1-L PCR fragment of L9F and L10R was digested by BamHI and 
EcoRI. The resulting fragment was inserted into the BamHI-
EcoRI sites of pGEX-6P-1. 
1 
pGEX-6P-1-JI PCR fragment of J1R and I5F was digested by BamHI and 
BsrGI. The resulting fragment was inserted into the BamHI-
BsrGI sites of pGEX-6P-Ltail. 
1 
pGEX-6P-1-IK PCR fragment of K5F and I6R was digested by BamHI and 
EcoRI. The resulting fragment was inserted into the BamHI-
EcoRI sites of pGEX-6P-1. 
1 
pGEX-6P-1-IKL PCR fragment of I6R and L9F was digested by BamHI and 
EcoRI. The resulting fragment was inserted into the BamHI-
EcoRI sites of pGEX-6P-1 vector  
1 
pGEX-6P-1-Ltail 
(pGLtail) 
The RsrII-BamHI fragment of pGEX-6P-1-L was inserted into 
the RsrII-BamHI sites of pGEX-6P-1-Mtail are digested by 
RsrII and BamHI. 
1 
pGEX-6P-1-Iter PCR fragment using I5F and I7R as primers was digested by 
BamHI and EcoRI. The resulting fragment was cloned into the 
BamHI-EcoRI sites of pGEX-6P-1. A terminator was 
introduced after the stop codon of gene I. 
1 
pGEX-6p-1-L1S 
(pGL1) 
QuikChange site-directed mutagenesis using L11F and L11R 
as primers and pGEX-6P-1-L as template DNA, was 
performed to construct C12S mutation in gene L. 
1 
pGEX-6p-1-L2S 
(pGL2) 
QuikChange site-directed mutagenesis using L12F and L12R 
as primers and pGEX-6P-1-L as template DNA, was 
performed to construct C39S mutation in gene L. 
1 
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pGEX-6p-1-L3S 
(pGL3) 
QuikChange site-directed mutagenesis using L13F and L13R 
as primers and pGEX-6P-1-L as template DNA, was 
performed to construct C140S mutation in gene L. 
1 
pGEX-6p-1-L4S 
(pGL4) 
QuikChange site-directed mutagenesis using L14F and L14R 
as primers and pGEX-6P-1-L as template DNA, was 
performed to construct C173S mutation in gene L. 
1 
pGEX-6p-1-L5S 
(pGL5) 
QuikChange site-directed mutagenesis using L15F and L15R 
as primers and pGEX-6P-1-L as template DNA, was 
performed to construct C182S mutation in gene L. 
1 
pGEX-6p-1-L6S 
(pGL6) 
QuikChange site-directed mutagenesis using L17F and L17R 
as primers and pGEX-6P-1-L as template DNA, was 
performed to construct C205S mutation in gene L. 
1 
pGEX-6p-1-L7S 
(pGL7) 
QuikChange site-directed mutagenesis using L18F and L18R 
as primers and pGEX-6P-1-L as template DNA, was 
performed to construct C208S mutation in gene L. 
1 
pGEX-6p-1-L8S 
(pGL8) 
QuikChange site-directed mutagenesis using L19F and L19R 
as primers and pGEX-6P-1-L as template DNA, was 
performed to construct C212S mutation in gene L. 
1 
pGEX-6p-1-L3M 
(pGL3M) 
QuikChange site-directed mutagenesis using L20F and L20R 
as primers and pGEX-6P-1-L as template DNA, was 
performed to construct C140M mutation in gene L. 
1 
pGEX-6p-1-L12 
(pGL12) 
QuikChange site-directed mutagenesis using L11F and L11R 
as primers and pGL2 as template DNA, was performed to 
construct C12S mutation in gene L. 
1 
pGEX-6p-1-L127 
(pGL127) 
QuikChange site-directed mutagenesis using L18F and L18R 
as primers and pGL12 as template DNA, was performed to 
construct C208S mutation in gene L. 
1 
pGEX-6p-1-L4C 
(pGL4C) 
QuikChange site-directed mutagenesis using L20F and L20R 
as primers and pGL127 as template DNA, was performed to 
construct C140M mutation in gene L. 
1 
pET21+ This vector contains an ampicillin resistance gene, a lacI gene 
and a T7 φ10 promoter adjacent to a Lac operator.  
4 
pET21-Ltail 
(pLtail) 
pEtail4 was digested by EarI, filled in by Klenow fragment 
and then digested by Xhol. The resulting fragment containing 
λ tail genes L-J was cloned into HindIII filled in, XhoI 
digestion of pET21+. 
2 
pIam PCR fragment using J1R / L1F as outer primers and IamF / 
IamR as inside primers was digested by BsrGI and RsrII. The 
resulting fragment was inserted into the BsrGI-RsrII sites of 
pLtail. 
1 
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pKam6 PCR fragment using J1R / L1F as outer primers and KamF / 
KamR as inside primers was digested by BsrGI and RsrII. The 
resulting fragment was inserted into the BsrGI-RsrII sites of 
pLtail. 
1 
pLdel pLtail was digested by RsrII and SacI. The resulting fragment 
containing λ tail genes K-J was filled in by Klenow and 
ligated. 
1 
pLtail-m1 PCR fragment using XD1F / XD2R as outer primers and 
XD17F / XD18R as inside primers was digested by BstBI and 
AvaI. The resulting fragment was inserted into the BstBI-AvaI 
sites of pLtail. 
1 
pLtail-m2 PCR fragment using XD1F / XD2R as outer primers and 
XD15F / XD16R as inside primers was digested by BstBI and 
AvaI. The resulting fragment was inserted into the BstBI-AvaI 
sites of pLtail. 
1 
pLtail-m3 PCR fragment using XD1F / XD2R as outer primers and 
XD13F / XD14R as inside primers was digested by BstBI and 
AvaI. The resulting fragment was inserted into the BstBI-AvaI 
sites of pLtail. 
1 
pLtail-m4 PCR fragment using XD9F / XD10R as outer primers and 
XD19F / XD20R as inside primers was digested by BstBI and 
AgeI. The resulting fragment was inserted into the BstBI-AgeI 
sites of pLtail. 
1 
pGtail The SacI-NsiI fragment of pT7-5-GT was inserted into the 
SacI-NsiI sites of pETail4. 
2 
pGtail-LT7 PCR fragment using L2R / H1F as outside primers and L21F / 
L21R as inside primers was digested by StuI and RsrII. The 
resulting fragment was cloned into the StuI-RsrII sites of 
pGtail. 
1 
pGtail-IT7 PCR fragment using L1F / J1R as outside primers and I8F / 
I9R as inside primers was digested by BsrGI and RsrII. The 
resulting fragment was cloned into the BsrGI-RsrII sites of 
pGtail. 
1 
pGtail-4S PCR fragment using H1F / L26R as outside primers and L25F 
/ L25R as inside primers was digested by StuI and RsrII. The 
resulting fragment was inserted into the StuI-RsrII sites of 
pGtail. 
1 
pGtail-5S PCR fragment using L23R and H1F as primers was digested 
by StuI and RsrII. The resulting fragment was inserted into the 
StuI-RsrII sites of pGtail. 
1 
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pGtail-6S PCR fragment using L1F / J1R as outside primers and L24F / 
L24R as inside primers was digested by BsrGI and RsrII. The 
resulting fragment was inserted into the BsrGI-RsrII sites of 
pGtail. 
1 
pGtail-8A The BsrGI-RsrII fragment of pEtail4-8A was inserted into the 
BsrGI-RsrII sites of pGtail. 
1 
pGtail-8H The BsrGI-RsrII fragment of pEtail4-8H was inserted into the 
BsrGI-RsrII sites of pGtail. 
1 
pGtail-8S PCR fragment using L1F / J1R as outside primers and L19F / 
L19R as inside primers was digested by BsrGI and RsrII. The 
resulting fragment was inserted into the BsrGI-RsrII sites of 
pGtail. 
1 
pEtail4 All 11 genes involved in λ tail assembly were cloned into 
pET21+ vector, resulting in pEtail. 
2 
pEtail4-Kam6 The BrsGI-RsrII fragment of pKam6 was inserted into the 
BsrGI-RsrII sites of pEtail4. 
1 
pEtail4-Kam768 PCR fragment using J1R / L1F as outer primers and K768F / 
K768R as inside primers was digested by BsrGI and RsrII. The 
resulting fragment was inserted into the BsrGI-RsrII sites of 
pEtail4. 
1 
pEtail4-Lam PCR fragment using L26R / H1F as outside primers and L27F 
/ L27R as inside primers was digested by StuI and RsrII. The 
resulting fragment was inserted into the StuI-RsrII sites of 
pEtail4. 
1 
pEtail4-4S The BsrGI-StuI fragment of pGtail-4S was inserted into the 
BsrGI-StuI sites of pEtail4. 
1 
pEtail4-5S The BsrGI-StuI fragment of pGtail-5S was inserted into the 
BsrGI-StuI sites of pEtail4. 
1 
pEtail4-6S The BsrGI-RsrII fragment of pGtail-6S was inserted into the 
BsrGI-RsrII sites of pEtail4. 
1 
pEtail4-7S PCR fragment using L1F / J1R as outside primers and L17F / 
L17R as inside primers was digested by BsrGI and RsrII. The 
resulting fragment was inserted into the BsrGI-RsrII sites of 
pEtail4. 
1 
pEtail4-8S The BsrGI-RsrII fragment of pGtail-8S was inserted into the 
BsrGI-RsrII sites of pEtail4. 
1 
pEtail4-8A PCR fragment using L1F / J1R as outside primers and L28F / 
L28R as inside primers was digested by BsrGI and RsrII. The 
resulting fragment was inserted into the BsrGI-RsrII sites of 
pEtail4. 
1 
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pEtail4-8H PCR fragment using L1F / J1R as outside primers and L29F / 
L29R as inside primers was digested by BsrGI and RsrII. The 
resulting fragment was inserted into the BsrGI-RsrII sites of 
pEtail4. 
1 
pLC3 This vector contains a kanamycin resistance gene, a lacI gene 
and a T7 promoter. It can be used to construct N-terminal 
MBP fusion protein. 
5 
pLC3-I PCR fragment using I3F and I4R as primers was digested by 
NdeI and BamHI. The resulting fragment was inserted into the 
NdeI-BamHI sites of pLC3. 
1 
pLC3-K PCR fragment using K3F and K4R as primers was digested by 
NdeI and BamHI. The resulting fragment was inserted into the 
NdeI-BamHI sites of pLC3. 
1 
pLC3-L PCR fragment using L7F and L8R as primers was digested by 
NdeI and BamHI. The resulting fragment was inserted into the 
NdeI-BamHI sites of pLC3. 
1 
pTQ30 This vector contains an ampicillin resistance gene and a T7 
promoter. It can be used to construct 6XHis tag to the N-
terminus of the target proteins. 
2 
pTQ30-J PCR fragment using J3F and J1R as primers was digested by 
BsrGI and SacI. The resulting fragment was inserted into the 
BsrGI-SacI sites of pTQ30-G-his-tail. 
1 
pTQ30-I PCR fragment using I1F and I2R as primers was digested by 
HindIII and SacI. The resulting fragment was inserted into the 
HindIII-SacI sites of pTQ30. 
1 
pTQ30-K PCR fragment using K1F and K2R as primers was digested by 
HindIII and SacI. The resulting fragment was inserted into the 
HindIII -SacI sites of pTQ30. 
1 
pTQ30-L PCR fragment using L5F and L4R as primers was digested by 
HindIII and SacI. The resulting fragment was inserted into the 
HindIII-SacI sites of pTQ30. 
1 
pTQ30-JI PCR fragment using J1R and I1F as primers was digested by 
BsrGI and SacI. The resulting fragment was inserted into the 
BsrGI-SacI sites of pTQ30-G-his-tail. 
1 
pTQ30-Ltail PCR fragment using L5F and L2R as primers was digested by 
RsrII and SacI. The resulting fragment was inserted into the 
RsrII-SacI sites of pTQ30-G-his-tail. 
1 
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*Source: 
1. Constructed for this study 
2. Constructed by Jun Xu  (Xu, 2001) 
3. GE Healthcare 
4. Novagen 
5. From Dr. Graham Hatfull lab (University of Pittsburgh) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 44
(2) Restriction digestion 
The digestion reaction was carried out as described in the enzyme manufactures (New England 
BioLab). 
 
(3) Ligation 
The ligation reactions were carried out in a 10 μl volume, including 1 U ligase, 1X ligation 
buffer, appropriate amounts of vectors and inserts, and ddH2O if needed. The reactions were 
incubated at 14℃ overnight. 
 
(4) Transformation 
1 μl ligation reaction or 1 μl of 1/100-1/10 diluted purified plasmid was mixed with 40 μl 
competent cells. After electroporation on a BioRAD GenePulser machine, the sample was 
resuspended in 1 ml LB, incubated at 37℃ for 40-60 minutes and plated on LB agar with 
appropriate antibiotics.  
 
(5) DNA gel electrophoresis 
DNA gel electrophoresis was performed as described with 0.8-1.2% agarose in 1X TAE buffer 
(Sambrook, 1989). The DNA was visualized by ethidium bromide staining. 
 
(6) DNA purification 
The PCR products were purified following the protocol described in QIAprep miniprep kit 
(QIAGEN). To purify DNA fragments from digestion reactions, the samples were first separated 
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on an agarose gel. Bands of interest were excised from the gel and the DNA fragments were 
purified by pressure-extrusion method (Gubin and Kincaid, 1998). 
 
(7) Sequencing 
The DNA samples were prepared as described and sent to GENEWIZ for sequencing. The 
results were analyzed by Sequencher. 
2.3.2 Polymerase chain reaction (PCR) 
(1) Regular PCR 
PCR reactions were performed in a 50 μl volume, including 1XPFU buffer, 0.5 μM of each 
primer, 0.2 mM of each dNTP, 5 μl of the template (for plasmid templates, the plasmid stocks 
were diluted 50-100 fold), and 2 units of PFU polymerase. The cycle was performed at 94℃ for 
50 seconds, 49℃ (the annealing temperature was adjusted in each experiment) for 50 seconds 
and 72℃ for 2.5 minutes for 20 cycles on a 9600 or 9700 GeneAmp PCR machine (Perkin-
Elmer).  
 
(2) Recombinant PCR 
Four primers (two “outside” and two “inside” primers) were needed for the recombinant PCR. 
Figure 2.1 illustrates the strategy of the recombinant PCR. The products from the first-round 
PCR were purified by QIAprep miniprep kit. The purified products were used as the template in 
the second-round PCR. 
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Figure 2.1 Overview of the recombinant PCR ( (Russell, 1990)with modifications). 
 
The recombinant PCR is a two-step PCR, which requires two “outside” primers (P1 / P2) and 
two “inside” primers (P3 / P4). It combines the two separate PCR products with overlapping 
sequence into one longer product. This technique can be used to make a base substitution, 
deletion or a small insertion. 
 
(a) The basic steps for making a base substitution by recombinant PCR is shown. Both of the 
inside primers, P3 and P4, contain the same mutation. Two separate PCR reactions are 
performed in the first-round PCR, using P1 / P3, and P2 / P4 as primers, respectively. The first-
round PCR products are purified by QIAprep miniprep kit. The overlapping sequence in the first-
round PCR products can be denatured and allowed to reanneal together to form a whole fragment 
with the target mutation. This long fragment can be amplified by P1 and P2 in the second-round 
PCR.  
 
(b) It shows inside primers for the creation of deletion. The remaining steps are the same as those 
for making a base substitution by recombinant PCR. 
 
(c) It shows inside primers for the creation of small insertion. The remaining steps are the same 
as those for making a base substitution by recombinant PCR. 
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(a) 
(b) 
(c) 
P1                              P4   
 
                                                             P3                              P2 
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(3) QuikChange site-directed mutagenesis 
The site-directed mutagenesis was performed following the QuikChange site-directed 
mutagenesis kit (Stratagene). The basic procedure for this experiment is shown in Figure 2.2.  
 
(4) Primers 
All the primers used in this study are listed in Table 2.2. 
2.3.3 Phage preparations 
(1) Heat induction of lysogens 
The lysogens were grown at 30℃ overnight in LB medium. The overnight culture was 1:100 
diluted into LB medium and grown at 37℃with vigorous shaking until it reached a density of 
about 3X108 cell/ml. The culture was then heat-induced at 43℃ for 18 minutes in a water bath. 
Subsequently, the culture was transferred to 37℃ for 3 hours. Cells were chilled and harvested 
by centrifugation at 8,000 RPM for 5 minutes. The pellet was resuspended in 1 ml λ dil buffer. 
Several drops of chloroform were added to lyse the cells. The pellet was removed by 
centrifugation at 8,000 RPM for 10 minutes. The supernatant was kept at 4℃. This method 
applies to prepare λSam7cI857 phage stock as well as some mutant phages stocks which are 
prepared from the induction of the appropriate C600 lysogens.  
 
(2) Revertant selection 
Phages with Sam7 mutation can grow on Ymel, but not on C600 or other E. coli strains (such as 
BL21(DE3)-Δtail) bearing the appropriate plasmid. In order to get rid of the Sam7 mutation,  
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Figure 2.2 Strategy for QuikChange site-directed mutagenesis (adapted from Stratagene’s 
QuikChange site-directed mutagenesis kit: instruction manual). 
 
The QuikChange site-directed mutagenesis kit can be used to generate point mutations, switch 
amino acids, delete or insert single or multiple amino acids in double-stranded plasmids. The 
basic procedure requires a supercoiled dsDNA plasmid with an insert of interest and two primers 
with the desired mutation. The plasmid is amplified by the oligonucleotide primers which anneal 
to the same sequence on opposite strands of the plasmid. This results in the nicked, circular 
strands. Subsequently, the parental DNA template is digested with DpnI and the circular, nicked 
dsDNA is transformed into XL1-Blue competent cells which can repair the nicks in the mutated 
plasmid. The mutated plasmid is extract as described above. 
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Table 2.2 Primers used in this study 
Primer Name Sequence 
J1R ccgttacgttgtatctgaac  
J3F gagctcatgggtaaaggaagcagtaa 
J4F ggatccatgggtaaaggaagcagt  
CD1F cggtggcagcagccaactcag 
XD2R cgaatcccatctcggcaagg 
XD9F ttggtctgctcaattttgac 
XD10R gaagggcttcgccatgtacc 
XD13F gtgatggtgatggtgatgcgggtcaataaatgcgatacga 
XD14R catcaccatcaccatcacccgatgtttgtggcgcaggg 
XD15F gtgatggtgatggtgatgcacactgctttcacgctggcg 
XD16R catcaccatcaccatcaccgtactgtcaccgtgaccga 
XD17F gtgatggtgatggtgatgtccgcgaaacgtcagcgga 
XD18R catcaccatcaccatcacggcaggacaacgtattcgatg 
XD19F gtgatggtgatggtgatggactttttccagcagctccttg  
XD20R catcaccatcaccatcacgagctgacggaggataacgc 
IamF gtggcgtattctagattgtcc 
IamR ggacaatctagaatacgccac 
I1F gagctcatggcagcgacgcacaca 
I2R  aagctttcagcgaccaatcaccaca 
I3F  catatggcagcgacgcacacactcc 
I4R  ggatcctcagcgaccaatcaccaca 
I5F ggatccatggcagcgacgcacaca 
I6R  gaattctcagcgaccaatcaccac  
I7R  gaattctcctcacgctccataaat 
I8F atggctagcatgactggtggacagcaaatgggttgatgcaaaatgttttatgtg 
I9R acccatttgctgtccaccagtcatgctagccatgcgaccaatcaccacaacctg 
L1F tttccgggacgtatcatgct 
L2R tgctgcatttatccttcgtg 
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L4R aagcttttactgcgaaagtttgtt 
L5F gagctcatgcaggatatccggcag 
L7F catatgcaggatatccggcaggaa 
L8R ggatccttactgcgaaagtttgtt 
L9F  ggatccatgcaggatatccggcag  
L10R gaattcttactgcgaaagtttgtt 
L11F  atgaaagcacacgtgcggagcagtc 
L11R gcacgtgtgctttcattcagtgtttc 
L12F tttctctaatgagcagaacgaaaaagg 
L12R tctgctcattagagaaaaaataacg 
L13F tgagcagagcagcgaattgagcgcgg 
L13R ttcgctgctctgctcaatgcgccag 
L14F tggcaaacaccagcacctggacctatc 
L14R ggtgctggtgtttgccagcatgatac 
L15F acgagagcggttatagcggcccggctg 
L15R taaccgctctcgtcaccgcgatagg 
L17F ataaaagcagcaaatgcttgagcgg 
L17R tgctgcttttatccttcgtgatatc 
L18F cagcaaaagcttgagcggttgtaag 
L18R gctcaagcttttgctgcatttatcc 
L19F agcggttcaaagttccgcaataacg 
L19R aactttgaaccgctcaagcatttgc 
L20F gagcagatgagcgaactgagcgcgg 
L20R gttcgctcatctgctcgatgcgccag 
L21F atggctagcatgactggtggacagcaaatgggtcaggatatccggcaggaaaca 
L21R acccatttgctgtccaccagtcatgctagccatcatcagttcaccacctgttc 
L23R gacagccggaccgctataaccgctctcgtc 
L24F acgaaggataaaagcagcaaatgc 
L24R gcatttgctgcttttatccttcgt 
L25F atgctggccaacaccagcacctggaccta 
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L25R taggtccaggtgctggtgttggccagcat 
L26R gtttgttaatggaaaggaagcc 
L27F ggaagatatgtagactctggtcgg 
L27R ccgaccagagtctacatatcttcc 
L28F atgcctgagcggtgctaagttcc 
L28R ggaacttagcaccgctcaggcat 
L29F ctgagcggtcataagttccgca 
L29R tgcggaacttatgaccgctcag 
KAMF gaagactagttgcaggcagaa 
KAMR ttctgcctgcaactagtcttc 
K768F acaaatggtagcgacgcaca  
K768R tgtgcgtcgctaccatttgt 
K1F  gagctcatgtcgccggaagactgg 
K2R  aagctttcacacgaaggtcgatgc 
K3F  catatgtcgccggaagactggctg  
K4R  ggatcctcacacgaaggtcgatgc 
K5F  ggatccatgtcgccggaagactgg  
K6R  gaattctcacacgaaggtcgatgc 
GST1F gctggcaagccacgtttgg 
GST1F gctggcaagccacgtttgg 
H1F cgctgaataacgtcatgtc 
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mutant phages with Sam7 mutation were plated on C600 for selection of revertants. About 106- 
107 phages were mixed with 100 μl overnight culture of C600. The mixture was incubated at 
37℃ for 15 minutes before they were plated on LB agar. After overnight incubation at 37℃, 
single plaques that can grow on C600 were picked and used for making phage plate stock. 
Phages made from the single plaques do not contain Sam7 mutation and therefore can be used in 
the spot complementation assay. 
 
(3) Plate stock 
Phages which do not exist as lysogens, such as the revertant phages, can be grown by plate stock 
method. A single plaque was picked from a fresh plate, resuspended in 1 ml λ dil buffer and 
incubated at 37℃ for about 1 hour. After this, 0.1 ml of the phage solution was mixed with 3 
drops of freshly grown Ymel cells (in LB / Mal) and the mixture was incubated at 37℃ for 15 
minutes. The mixture was then mixed with 4 ml of diluted soft agar (equal volume of soft agar 
and KG), poured onto a fresh tryptone agar plate, and incubated at 37℃ right-side up to 
confluent lysis (about 6-8 hours). The top soft agar was scraped into a sterile centrifuge tube and 
several drops of chloroform were added. The mixture was homogenized by vortexing and the 
pellet was removed by centrifugation at 8,000 RPM for 10 minutes.  
 
(4) Plaque assay 
The phage stock was made series dilution. 100 μl of the diluted phage was mixed with 100 μl of 
overnight bacteria cells and incubated at 37℃ for 15 minutes to allow phage adsorption. 
Subsequentely, the solution was mixed with 3-4 ml of melted soft agar and poured on LB agar 
plates. The plates were incubated at 37℃ overnight. 
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(5) Preparation of concentrated tail-defective lysates 
The overnight culture of appropriate 594 lysogen was 104-105 diluted into M9A medium and 
grown at 28℃ overnight. The next morning, the growth temperature was shifted to 30℃ until 
they reached about 3X108 cell/ml. The culture was then transferred to a 43℃ water bath for 18 
min for heat induction. After 3 hours’ growth at 37℃, the culture was chilled and harvested by 
centrifugation at 4000 g for 10 minutes. The pellet was resuspended in 1/250-1/300 of the culture 
volume in 0.2 M Tris-HCl (pH 8.8). 
 
(6) λ head preparation 
The head lysate was prepared from 594(λVam750Sam7cI857) lysogen in the same way as 
making conecentrated tail-defective lysates except that cells were grown in LB medium instead 
of M9A medium. After cells were harvested, they were resuspended in head buffer. Several 
drops of chloroform were added to lyse the cells. After lysis, 20 μg/ml DNase I was added and 
the mixture was incubated in a 24℃ water bath for about 5 minutes to promote DNase action. 
The pellet was removed by centrifugation at 8,000 RPM for 15 minutes. The supernatant was 
loaded onto the top of 1.5 ml of 25% sucrose and centrifuged in Ti80 at 30,000 RPM for 30 
minutes at 4℃. After centrifugation, appropriate amount of head buffer was added and the 
solution was incubated overnight at 4℃ to allow the head to be dissolved. The undissolved pellet 
was removed by low speed centrifugation and the supernatant was used for the head-tail joining 
reaction.   
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2.3.4 Protein manipulation 
(1) Protein expression 
Cells with the target plasmid were grown in LB with appropriate antibiotics (50 μg/ml Amp and 
25 μg/ml Cam for BL21(DE3)-Δtail pLysS with pET21+ / pTQ30 / pGEX-6p-1 based plasmids, 
25 μg/ml Kan and 25 μg/ml Cam for BL21 StarTM(DE3) pLysS with pLC3 based plasmids). The 
next morning, the overnight culture was inoculated into LB medium with appropriate antibiotics 
by 1:500-1:1000 dilution. The culture was grown at 37℃ until they reached a density of about 
4X108 cell/ml. IPTG (1 mM for pET21+ / pGEX-6p-1 / pLC3 based plasmids and 0.4 mM for 
pTQ30 based plasmids) was added to induce protein expression at 37℃ for about 2.5 hours. 
Alternatively, cells can grow at 30℃ until they reached a density of about 4X108 cell/ml. They 
were induced with 0.4 mM IPTG overnight at 28℃. Cells were chilled, harvested and 
resuspended in an appropriate buffer. They were lysed by sonication and the pellet was removed 
by centrifugation at 10,000 RPM (for lysates used for amylose or glutathione affinity 
chromatography) or 13,000 RPM (for lysates used for nickel affinity chromatography) for 20 
minutes at 4℃. 
 
(2) Preparation of 35S-Met labeled proteins 
A single colony was picked from a fresh plate and resuspended in 1 ml of M9-MC medium. This 
solution was then made 1/100 dilution into a larger volume of M9-MC medium with appropriate 
antibiotics in a 25 ml flask and the culture was left standing overnight at 30℃. The next morning, 
the culture was transferred to a 37℃ water bath with shaking until it reached a density of about 
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3X108 cell/ml. The temperature was shifted to 30℃ and appropritate amount of IPTG (1 mM for 
pET21+ / pLC3 / pGEX-6p-1 based plasmids or 0.4 mM for pTQ30 based plasmids) was added 
to induce protein expression for 30 minutes. After this, 200 μg/ml rifampicin was added to shut 
down host gene expression for 20 minutes. 35S-Met was added to 5-10 μCi/ml and the culture 
was grown at 30℃ for 1 hour. The cells were chilled and harvested by centrifugation at 8,000 
RPM for 10 minutes. The pellet was resuspended in 1/10 culture volume of cold lysis buffer. 
Triton X-100 was added to a final concentration of 0.1% and the mixture was warmed to 24℃ 
for about 5 minutes to promote lysozyme action. Subsequently, MgSO4 and DNase I were added 
to a final concentration of 7.5 mM and 20 μg/ml, respectively. The mixture was incubated at 
24℃ for about 5 minutes to promote DNase activity. The supernatant was separated from the 
pellet by centrifugation at 8,000 RPM for 15 minutes at 4℃. 
 
For radiolabeled samples used for the sucrose velocity gradient followed by the in vitro 
complementation assay, the cells were harvested by centrifugation at 4,000 g for 10 minutes at 
4℃ and resuspended in 1/50-1/100 of the culture volume of Buffer A. Cells were lysed by 
freezing in the liquid nitrogen for 10 seconds and thawing at room temperature for about 15 
minutes. The pellet was removed by centrifugation at 6,000 g for 15 minutes at 4℃. The 
supernatant was further analyzed by a 10-25% sucrose velocity gradient. 
 
 (3) Pulse-chase experiment 
Before addition of 35S-Met, the procedure for this experiment is the same as that of the 
preparation of 35S-Met labeled proteins as described above except that the temperature was kept 
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at 37℃ after induction. After addition of rifampicin for 20 minutes, 2 μg/ml of 35S-Met was 
added for 30 seconds and then 1000-fold excess of cold methionine was added. Samples were 
taken at 0 (right before addition of cold methionine), 2, 5, 10, 15, 20, 30, 40, 50, and 60 minutes 
after addition of cold methionine. Each sample was TCA precipitated and resuspended in 40 μl 
of 1X SDS sample buffer. The samples were boiled for 2.5 minutes before they were loaded onto 
SDS-PAGE. 
 
(4) TCA precipitation of proteins 
Cold TCA was added to the protein sample with a ratio of about 4:1 (TCA:protein) The mixture 
was vortexed immediately, incubated on ice for 10-30 minutes and then centrifuged at 12,000 
RPM for 15 minutes at 4℃. The supernatant was aspirated and 0.5-1 ml of ice cold acetone was 
added to each pellet to get rid of residual TCA. The sample was incubated at -20℃ for more than 
30 minutes before it was centrifuged at 12,000 RPM for 10 minutes at 4℃. The supernatant was 
aspirated and the pellet was placed in a desiccator for 15 minutes. The pellet was resuspended in 
1X SDS sample buffer and boiled for 2.5 minutes. 
 
(5) Nickel affinity chromatography 
This experiment was carried out as described in Novagen protocols with buffers modified. In 
brief, the column was first charged with 4 bed volumes of 1X changing buffer and then 
equilibrated with 3 bed volumes of 1X binding buffer. Subsequently, the sample was loaded onto 
the column. This was followed by 10 bed volumes of 1X binding buffer, 8 bed volumes of 1X 
washing buffer and 3 bed volumes of 1X elute buffer. 
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(6) Amylose affinity chromatography 
This experiment was carried out as described in the instruction manual for pMALTM protein 
fusion and purification system (New England BioLabs) with buffers modified. Brief, the column 
was equilibrated with 8 bed volumes of 1X column buffer. The sample was first diluted to reduce 
the protein to about 2.5 mg/ml before it was loaded onto the column. After this, the column was 
first washed with 12 bed volumes of 1X column buffer and then eluted with 3 bed volumes of 1X 
elution buffer. The eluted protein was dialyzed in 1X TEV buffer and then used for AcTEV 
protease digestion following the instruction (Invitrogen). 
 
(7) Glutathione affinity chromatography 
This experiment was performed following the instruction manual for Glutathione Sepharose 4B 
(Amersham Biosciences) with buffers modified. Briefly, the column was first equilibrated with 
ice cold 1XPBS. After the sample was loaded, the column was washed with 10 bed volumes of 
ice cold 1XPBS and then eluted with 5 bed volumes of 1X elution buffer. The eluted protein was 
dialyzed in 1X PreScission cleavage buffer and used for PreScission Protease cleavage following 
the instructions (GE Healthcare). 
 
(8) Hydroxyapatite chromatography 
The hydroxyapatite chromatography was carried out as described in the instruction manual for 
pMALTM protein fusion and purification system (New England BioLabs). Briefly, the column 
was first equilibrated with 1X wash buffer and then the sample was loaded onto the column. The 
column was washed with 10 bed volumes of 1X wash buffer and then eluted with 3 bed volumes 
of 1X elution buffer. The elution fractions were assayed for protein A280. 
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(9) Ammonium sulfate precipitation 
Appropriate amount of solid (NH4)2SO4 was slowly added to the sample, which was kept stirring 
on an ice box, until the desired concentration. After this, the solution was kept stirring for about 
1 hour to fully equilibrate. The solution was then centrifuged at 13,000 RPM for 20 minutes at 
4℃ to pellet out protein. More solid ammonium sulfate was added to the supernatant to make 
the next desired concentration, and the stirring and centrifugation steps were repeated. Each 
pellet was resuspended in the same volume of appropriate buffer. 
 
(10) Co-immunoprecipitation (Co-IP) 
The Co-IP reaction was performed in a 200 μl reaction with 1 μl of 1:5 diluted T7-tag antibody 
and the appropriate amount of the sample. The mixture was incubated on a rotating wheel for 2 
hours at 4℃. Protein G Sepharose 4 Fast Flow slurry was washed 3 times with Co-IP buffer 
before it was added to the mixture. After overnight incubation with protein G-coupled beads on a 
rotating wheel, each sample was washed 3 times with Co-IP buffer, resuspended in 20 μl of 1X 
SDS sample buffer and boiled for 5 minutes.  
 
(11) SDS polyacrylamide gel electrophoresis 
The experiment was performed as described (Laemmli, 1970). The SDS gels were run at 150 V 
constant voltage until the blue dye ran out of the gel. Gels were stained with coomassie blue. 
 
(12) Densitometry 
For SDS gels with radioactive samples, the gels were dried before they were exposed to Kodak 
BioMax MR films. For quantification purpose, the gels were exposed to the films for several 
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different times and the experiments were generally repeated 1-3 times. After development of the 
films, they were scanned and analyzed by Kodak 1D image analysis software (version 3.5) 
following the instruction. The net intensity of the bands of interest was correlated to the exposure 
time. A curve was obtained by plotting the net intensity of the target bands against the exposure 
time. If a number was significantly deviated from the curve, it was thought to be inaccurate and 
was not used for further analysis. For the estimation of the stoichiometries of the tail tip proteins, 
the copy numbers of the tail tip proteins were corrected for the number of sulfur atoms in the 
proteins and they were normalized to either 3 copies of gpJ or 6 copies of gpU. 
2.3.5 Complementation 
(1) Head-tail joining reaction 
The head-tail joining reaction was carried out as described (Weigle, 1966). 10 μl of tail and 10 μl 
of head were mixed with 80 μl of λ dil buffer. The mixture was incubated at room temperature 
for 30-60 minutes before they were titered for phage production. 
 
(2) In vitro complementation assay 
The In vitro complementation assay was performed as described (Katsura and Kuhl, 1975). 15 μl 
of each fraction from the sucrose gradient was mixed with 10 μl of concentrated tail-defective 
lysates. The mixtures were then frozen in liquid nitrogen for 10 seconds and then incubated at 
room temperature overnight. Subsequently, 0.1 ml of λ dil buffer containing 10 μg/ml DNase I 
was used to suspend the mixtures. The mixtures were diluted by λ dil buffer and titered for phage 
production. 
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(3) In vivo spot complementation assay 
Cells containing the target plasmid were grown in LB with appropriate antibiotics at 37℃ 
overnight. 150 μl of the overnight cultures were plated on LB agar plates. 4 μl of 10-fold diluted 
phages (104-108 PFU/ml) were spotted on the lawn of bacteria. The plates were incubated at 
37℃ overnight. 
2.3.6 Separation of λ tail / tail tip assembly intermediates 
(1) Sucrose velocity gradient 
The sucrose velocity gradient was performed as described (Katsura and Kuhl, 1975). The sample 
was loaded onto a 10-25% linear sucrose gradient in 0.2 M Tris-HCl buffer (pH 7.8) and 
centrifuged in an SW60Ti rotor at 58,000 RPM for 3.5 hours at 4℃. After this, the centrifuge 
tubes were punctured at the bottom and the gradients were collected into 12-13 fractions. 
 
(2) Precipitation of λ tail / tail tip assembly intermediates by E. coli cells 
The experiment was performed as described in (Tsui and Hendrix, 1983). Briefly, the 
radiolabeled tail lysate was incubated with excess amounts of E. coli cells at 4℃ for 1 hour or 
overnight to allow the binding of gpJ to LamB receptors. Subsequently, the mixture was washed 
3 times with λ dil buffer by centrifugation at 6,000 RPM for 10 minutes to remove the unbound 
proteins. The bound proteins were resuspended in 1X SDS sample buffer and boiled for 2.5 
minutes. 
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(3) Glycerol gradient to separate λ tail 
The radiolabeled tail lysate was loaded onto a 10-30% glycerol gradient in TKG buffer and 
centrifuged in an SW41 rotor at 40,000 RPM for 3.5 hours at 4℃. After centrifugation, a whole 
was punctured at the bottom of the gradient tube and the gradient was collected into 12-13 
fractions. 
2.4 SEPARATION OF λ PHAGE BY CESIUM CHLORIDE STEP GRADIENT 
The phage solution was layered on 4.5 ml of the cesium chloride gradient, including 1 ml of 10% 
glycerol in λ dil buffer, 2 ml of 1.4 g/cm3 CsCl and 1.5 ml of 1.6 g/cm3 CsCl. After 
centrifugation in an SW41 rotor at 30,000 RPM for 90 minutes at 20℃, a whole was punctured 
at the bottom of the tube and about 1/3 from the bottom of the gradient was collected. 
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3.0 EXPRESSION AND PURIFICATION OF λ TAIL TIP PROTEINS 
3.1 INTRODUCTION 
The tail tip of phage λ, located at the distal end of the tail, is composed of a thin, central tail fiber 
and a conical part (Katsura, 1983). It recognizes host receptors and may undergo conformational 
change and protein rearrangement in order to allow the passage of the phage genome into the 
cytoplasm. The general mechanism of DNA injection remains an open question. 
 
The assembly of the tail tip begins with the formation of a 15S complex by 3 copies of gpJ and 
this is followed by the sequential addition of gpI, gpL and gpK. Although the order of the 
interactions between these proteins has been known for many years, little is know about the 
function and positions of the tail tip proteins in the structure, neither do we know about the 
composition and stoichiometry of the tail tip complex. Besides, the tail is generally believed to 
be a 3-fold symmetric structure. Therefore, it will be of interest to know how the 4 side tail fibers 
are bound to the 3-fold symmetric tail. 
 
In order to answer these questions, it is essential to study the structure of the λ tail tip. In this 
chapter, I will describe attempts to express and purify the λ tail tip complex and the individual 
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tail tip proteins. A long term goal of this work, as has been done for the T4 baseplate, is to 
determine the composition and stoichiometry of the λ tail tip by fitting X-ray structures of the 
individual tail tip proteins into the cryo-EM density of the tail tip complex. 
3.2 ESTABLISHMENT OF THE IDENTITIES OF gpI, gpL AND gpK 
At lease four gene products are involved in lambda tail tip assembly. Except for gpJ, the 
identities of the remaining three tail tip proteins are not well established. In order to identify 
these proteins, amber mutation or deletion is used to delete most of the target gene product.  
3.2.1 Construction of amber mutation / deletion in the gene of interest 
The pET21+ vector (Novagen) has a lacI gene and has a T7 promoter adjacent to a lac operator. 
This vector provides tighter control of gene expression under non-induced conditions. The four 
genes encoding λ tail tip proteins were cloned into this vector, resulting in plasmid pLtail (Xu, 
2001). An amber mutation (in gene I or gene K) or deletion (in gene L) was introduced to delete 
most of the target gene product. Table 3.1 is a description of the plasmids used in this section. 
3.2.2 The amber / deletion mutant has little biological activity in vivo 
After construction of each mutation, I wanted to ask if the amber mutation / deletion abolishes 
the ability of the target gene product to complement in vivo. This can be done by the spot  
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Table 3.1 Description of plasmids used in the spot complementation assay. 
 
The pLtail plasmid encodes all four proteins required for lambda tail tip assembly. The pIam, 
pLdel and pKam6 plasmids are derivatives of pLtail. The amber mutations were introduced by 
recombinant PCR whereas the deletion was made by restriction digestion of pLtail plasmid (see 
MATERIALS AND METHODS). 
Plasmid Vector used Tail Proteins Description 
pET21+ pET21+ None Empty vector 
pLtail pET21+ gpJ, gpI, gpL, 
gpK 
λ tail genes J, I, K and L were cloned into the 
pET21+ vector. 
pIam pET21+ gpJ, gpL, gpK An amber mutation was introduced around the 
middle of gene I resulting in a 102-amino-acid 
amber fragment. 
pLdel pET21+ gpJ, gpI, gpK A deletion was made by digesting pLtail with 
SacI and RsrII. 716 base pairs, including the 
first 559 base pairs of gene L, were deleted 
from pLtail. 
pKam6 pET21+ gpJ, gpI, gpL An amber mutation was made in the sixth 
codon of gene K, resulting in a 5-amino-acid 
amber fragment. 
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complementation assay. In this experiment, decreasing concentrations of phage are spotted on a 
lawn of cells containing the target plasmid. The phage usually carries an amber mutation in one 
of the tail genes and therefore is unable to form plaques. If proteins expressed from the plasmid 
can complement the defect, a clear spot will form. The better the complementation, the fewer 
phages that are required to form a clear spot. 
 
Tables 3.1 and 3.2 list the plasmids and phages used in the experiment. Each plasmid was 
spotted with λIam838cI857, λLam756cI857 and λKam768cI857. Figure 3.1 shows that no 
complementation activity is found between pIam and λIam838cI857, and, pLdel and 
λLam756cI857. Phage λKam768cI857 does make plaques on the strain carrying pKam6 at about 
0.1% efficiency. Since pKam6 encodes only the first 5 amino acids of gpK, it is most likely that 
this low level of phage growth is due to recombination between Kam6 in the plasmid and 
Kam768 in the superinfecting phage at low frequency to give a wildtype sequence instead of 
complementation. This hypothesis is suggested by the fact that the level of growth is insensitive 
to induction of expression from the plasmid. Therefore, the amber mutation / deletion in the gene 
of interest abolishes the biological activity of the target gene product. In addition, the result also 
shows that the amber mutation or deletion has little effect on the growth of the other two amber 
phages tested, which suggests that the amber mutation / deletion has little polar effect on the 
other two genes examined. 
3.2.3 Identification of gpI, gpL and gpK 
The tail tip proteins expressed from the target plasmids were radiolabeled by 35S-Met and the 
crude lysates were prepared for SDS-PAGE followed by autoradiography (see MATERIALS  
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Table 3.2 Phages used in the spot complementation assay. 
Phage (abbreviation) Defects 
λIam838cI857 (I838) No gpI, cI temperature sensitive mutant 
λLam756cI857 (L756) No gpL, cI temperature sensitive mutant 
λKam768cI857 (K768) No gpK, cI temperature sensitive mutant 
 
Note: cI857 is a temperature sensitive mutation in gene cI. It prevents lysogenic  
growth of λ phage at 37℃. 
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Figure 3.1 The mutant protein has little in vivo complementation activity. 
 
BL21(DE3) is an E. coli strain containing a λ prophage, DE3. In order to minimize the effect of 
the tail proteins expressed from the prophage and to prevent recombination between plasmid and 
prophage, the tail genes of DE3 were knocked out, resulting in BL21(DE3)-Δtail (Xu, 2001). 
This new strain was used as the host for the target plasmids in this assay. λIam838cI857 (I838), 
λLam756cI857 (L756) and λKam768cI857 (K768) were used as the test phages. Phages were 
spotted onto each row with 10-fold decrease in the number from left to right with the left-most 
spot having about 4X105 phages. The first column indicates the plasmid used. The second and 
third column indicates the concentration of isopropyl-β-D-thiogalactopyranoside (IPTG) added 
to the top soft agar. The last column is about the phage used and its defect. 
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AND METHODS). Table 3.3 shows the predicted molecular weights of the target proteins and 
Figure 3.2 shows the identities of these proteins on SDS-PAGE. GpI band is absent from the 
sample containing pIam plasmid (lane 2) whereas gpL or gpK band is absent from the sample 
containing pLdel or pKam6 (lanes 3-4). The position where gpI appears on SDS-PAGE is 
consistent with the predicted molecular weight. In terms of gpL and gpK, the positions where 
they migrate on SDS-PAGE are a little different the positions expected from the calculated 
molecular weights. 
3.3 EXPRESSION OF THE λ TAIL TIP COMPLEX 
3.3.1 Addition of 6XHis tag to gpJ 
The pLtail plasmid encodes all four proteins involved in lambda tail tip assembly. I first tried to 
purify the complex by nickel affinity chromatography. This can be done by labeling gpJ with a 
polyhistidine tag since gpJ is the first protein involved in λ tail tip assembly and anything 
associated with it will be co-purified. Early studies in LamB mutants tightly blocking phage 
adsorption revealed that amino acid substitutions at the C-terminal part of gpJ are responsible for 
the extended host range (Hofnung et al., 1976; Werts et al., 1994). These results imply that the 
C-terminal part of gpJ may be exposed and directly interact with E. coli LamB. Therefore, I tried 
to insert a 6X or 8XHis tag to four different positions of the C-terminal part of gpJ (Table 3.4).  
To minimize the disruption of helices and strands, each polyhistidine tag was inserted into the 
position where it is predicted to be coils. I also tried not to disrupt the sites which are found to be 
responsible for extended host range. The detailed information about the predicted secondary  
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Table 3.3 Predicted molecular weights of gpI, gpL and gpK. 
 
The protein sequences used for calculation are based on the DNA sequences of the target genes. 
The predicted molecular weights of the tail tip proteins are obtained from the following website: 
http://www.encorbio.com/protocols/Prot-MW.htm. 
Protein Predicted molecular weight (kDa) 
gpI 23.1 
gpL 25.7 
gpK 23.0 
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Figure 3.2 Establishment of the identities of gpI, gpL and gpK. 
 
The pLysS plasmid produces T7 lysozyme which reduces basal level expression of the genes of 
interest. Each target plasmid was co-transformed with pLysS into strain BL21(DE3)-Δtail. Cells 
were grown in M9-MC medium with antibiotics at 37℃. When they reached a density of about 
3X108 cell/ml, IPTG (1 mM) was added to induce protein expression. After 30 minutes, 
rifampicin (200 μg/ml) was added to shut down host strain protein expression. About 20 minutes 
after the addition of rifampicin, 100 μl sample was taken from each culture and 0.25 μl 35S-Met 
(10 mCi/ml) was added to each sample for 15 minutes at 37℃. Subsequently, samples were 
chilled and centrifuged at 8000 RPM for 5 minutes at 4℃. The pellet was resuspended in 40 μl 
1XSDS sample buffer. Each sample was boiled for 2.5 minutes before they were loaded onto 
15% SDS-PAGE. Proteins were visualized by autoradiography. The positions of the low 
molecular mass markers are indicated on the left. 
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Table 3.4 Description of plasmids used in the spot complementation assay. 
 
All plasmids list below are derived from pET21+ vector. The polyhistidine tag was introduced 
into gpJ by recombinant PCR. 
Plasmid Tail proteins Description 
pET21+ None Empty vector 
pLtail gpJ, gpI, gpL, gpK Encodes wildtype tail tip proteins 
pLtail-m1 gpJ-m1, gpI, gpL, gpK Differs from pLtail in that it encodes gpJ with an 
8XHis tag inserted between 1043th and 1044th residues 
of wildtype gpJ. 
pLtail-m2 gpJ-m2, gpI, gpL, gpK Differs from pLtail in that it encodes gpJ with a 6XHis 
tag inserted between 1013th and 1014th residues of 
wildtype gpJ. 
pLtail-m3 gpJ-m3, gpI, gpL, gpK Differs from pLtail in that it encodes gpJ with a 6XHis 
tag inserted between 907th and 908th residues of 
wildtype gpJ. 
pLtail-m4 gpJ-m4, gpI, gpL, gpK Differs from pLtail in that it encodes gpJ with a 6XHis 
tag inserted between 835th and 836th residues of 
wildtype gpJ. 
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structure of the C-terminal part of gpJ, sites responsible for extended host range and the positions 
where the polyhistidine tags are inserted is shown in Figure 3.3. 
3.3.2 Effects of the polyhistidine tag on the biological activity of λ gpJ 
After construction of each plasmid, a spot complementation assay was performed to determine 
the biological activity of the recombinant protein. Each target plasmid was tested for its ability to 
complement λJam27cI857 which carries an amber mutation in gene J. Figure 3.4 shows that in 
the absence of inducer, the recombinant proteins can complement almost as well as the wildtype 
protein. However, when lactose is present, only gpJ-m3 can complement almost as well as the 
wildtype protein. Decreased complementation ability is observed in the remaining three mutants. 
These results suggest that gpJ-m1, gpJ-m2 and gpJ-m4 may become precipitated at the presence 
of the inducer. It may also be that these three mutant proteins are able to form heterotrimers with 
the amber fragment of gpJ in λJam27cI857 in the absence of the inducer and the heterotrimers 
may become homotrimers when inducer is present.  
3.3.3 Expression of the tail tip complex 
A time-course expression of the tail tip proteins was carried out and the result is shown in Figure 
3.5. Except for gpJ, it is very hard to see the remaining three tail proteins on SDS-PAGE by 
coomassie blue stain. The fact that the majority of gpJ is present in the pellet suggests that most 
of the tail tip proteins are insoluble. Different expression temperatures (37℃, 30℃ and 26℃) 
and different buffer conditions (such as detergent concentrations) have been tried with little 
improvement in the solubility of gpJ. In addition to the polyhistidine tag, I also tried to clone all 
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Figure 3.3 The C-terminal part of λ gpJ. 
 
λ gene J encodes a 1132 amino acid protein. The last 332 residues are shown here. The 
secondary structure is predicted by PSIPRED (http://bioinf.cs.ucl.ac.uk/psipred/). The residues 
which are found to be responsible for extended host range are bolded and underlined. Red arrows 
indicate the positions where the polyhistidine tags were inserted. 
 
Conf: Confidence (0=low, 9=high) 
Pred: Predicted secondary structure (H=helix, E=strand, C=coil) 
AA: Target sequence 
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Conf: 7452434678324556652435603568876412054365 
Pred: CCCCEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHEECCC 
  AA: VEAVGRASDDAEGYLDFFKGKITESHLGKELLEKVELTED 
             810       820       830       840 
 
 
Conf: 335678999999975435776887766511168379987799988578906899999820 
Pred: CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCEEEEEEEEEEECCCCCEEEEEEEEEE 
  AA: NASRLEEFSKEWKDASDKWNAMWAVKIEQTKDGKHYVAGIGLSMEDTEEGKLSQFLVAAN 
             850       860       870       880       890       900 
 
 
Conf: 279996799938604999998798166761157781114678112168835675899872 
Pred: EEEEEECCCCCEEEEEEEECCEEEECHHHHCCCCEEEEEECCCCEEEEECCCCCEEEEEE 
  AA: RIAFIDPANGNETPMFVAQGNQIFMNDVFLKRLTAPTITSGGNPPAFSLTPDGKLTAKNA 
             910       920       930       940       950       960 
 
 
Conf: 673379985553001899222599779999998610454376303445788723537529 
Pred: EEEEEEEECCCCCCCEEECCCEEEEEEEEEEEEEEEEEEEEEECCCCCCCCCCEECCCEE 
  AA: DISGSVNANSGTLSNVTIAENCTINGTLRAEKIVGDIVKAASAAFPRQRESSVDWPSGTR 
             970       980       990      1000      1010      1020 
 
 
Conf: 999688888474399582778113605778865047999999877089121215676356 
Pred: EEEECCCCCCCCEEEECCEEECCEECCCCCCCCEEEEEEEEEECCEEEECEECCCCCCEE 
  AA: TVTVTDDHPFDRQIVVLPLTFRGSKRTVSGRTTYSMCYLKVLMNGAVIYDGAANEAVQVF 
            1030      1040      1050      1060      1070      1080 
 
 
Conf: 7999447888559999999860346788996087657999997012671649 
Pred: EEEEECCCCCCEEEEEEEEEEECCCCCCCCCCEEEEEEEEEEECCCCCCEEC 
  AA: SRIVDMPAGRGNVILTFTLTSTRHSADIPPYTFASDVQVMVIKKQALGISVV 
            1090      1100      1110      1120      1130 
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Figure 3.4 Spot complementation assay for the polyhistidine tagged gpJ. BL21(DE3)-Δtail is the 
host strain for the plasmids of interest. Each plasmid was tested for its ability to complement 
λJam27cI857, which encodes a defective amber fragment of gpJ. The experiment was carried out 
as described previously. No lactose or 1% lactose is present in the top soft agar. 
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Figure 3.5 Expression of λ tail tip complex. 
 
BL21(DE3)-△tail with the target plasmid was grown in LB with antibiotics at 37℃ until it 
reached about 4X108 cell/ml. IPTG (1 mM) was added to induce protein expression. 100 μl 
sample was taken at 0 minute, 1 hour and 2.5 hours after induction. Subsequently, the culture 
was harvested and resuspend in 1Xbinding buffer. Cells were lysed by sonication and the pellet 
was removed from the supernatant by centrifugation at 13,000 RPM 20 minutes at 4℃. The 
samples were prepared for 15% SDS-PAGE and visualized by coomassie blue stain. This 
experiment was done for all the mutants, but the results look very similar. Therefore, only the 
result for pLtail-m3 is shown here. Except for gpJ, the yield of the remaining three tail tip 
proteins is too low to be detected on SDS-PAGE by coomassie blue stain. 
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four tail tip genes into the pGEX-6p-1 vector which adds a GST tag at the N-terminus of gpL. 
Although the yield of the tail tip complex are high (based on the amounts of gpJ), most of them 
are insoluble (data not shown). 
3.4 PURIFICATION OF λ TAIL TIP PROTEINS 
As described above, I had some trouble in obtaining a soluble form of the tail tip complex. 
Subsequently, I tried to express and purify each of the individual tail tip proteins. gpJ will not be 
described below since the addition of 6XHis tag, MBP, or GST to the C-terminus of gpJ results 
in an inactive protein (data not shown). Besides, although the recombinant gpJ is produced in 
large amounts, the majority of the recombinant protein is insoluble (data not shown). The 
expression and purification of the remaining three tail tip proteins will be described below. 
3.4.1 Construction of the recombinant proteins 
Three different tags were used to help purify the tail tip proteins. Below is a description of the 
vectors used for the construction of the recombinant proteins. 
 
pTQ30: The EcoRI-XbaI fragment of pQE30 (QIAGEN) was cloned into the EcoRI- XbaI sites 
of pT7-5, resulting in pTQ30. Proteins expressed from this vector are under the control of the T7 
promoter. In my experiments, the target gene was inserted into the HindIII-SacI sites of pTQ30. 
BL21(DE3)-Δtail is used as the host strain. A 16-amino-acid sequence 
(MRGSHHHHHHGSACEL), including a 6XHis tag, is added to the N-terminus of the target 
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protein. The main advantage of this system is that the short polyhistidine tag can minimize the 
effect of the foreign sequence on the activity of the target protein. 
 
pLC3: The PCR fragment encoding N-terminal 6XHis tagged maltose binding protein (MBP) 
was inserted into the NcoI-NdeI sites of pET28b vector. The resulting construct (pLC3) can be 
used for the construction of proteins with MBP at the N-terminus. The MBP fusion protein can 
be cleaved by AcTEV protease, which recognizes the seven-amino-acid sequence ENLYFQG 
and cleaves between glutamine (Q) and glycine (G) with high specificity. The 29-kDa protease 
contains a polyhistidine tag at the N-terminus and therefore can be removed by affinity 
chromatography. In the experiments, the target gene was cloned into the BamHI-NdeI sites of 
pLC3. After AcTEV protease digestion, an additional 5-amino-acid sequence (GDITH) remains 
at the N-terminus of the target protein.   
 
pGEX-6p-1: The pGEX-6p-1 vector (GE healthcare) contains an internal lacIq gene and a tac 
promoter.  This vector can be used for the construction of N-terminal glutathione S-transferase 
(GST) fusion proteins. In the experiments, the gene of interest was cloned into the BamHI-EcoRI 
sites of the vector. GST can be cleaved from the target protein by PreScission Protease. The 
protease recognizes a subset of sequences, including the core amino acid sequence LFQGP, and 
cleaves between glutamine (Q) and glycine (G) residues with high specificity. The 46-kDa 
PreScission Protease can be easily removed from the cleavage reaction by affinity 
chromatography since it is fused to GST. The main advantage of using PreScission Protease is 
that it allows low-temperature cleavage (5℃) of fusion proteins, which minimizes the  
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degradation of the target proteins. After cleavage, a 5-amino-acid sequence (GPLGS) remains at 
the N-terminus of the target protein.  
3.4.2 Determination of the biological activities of the recombinant proteins 
Each recombinant protein was tested for its ability to complement in vivo. The spot 
complementation assay was carried out as described previously. Table 3.5 is a description of the 
plasmids used and Figures 3.6-3.8 show the results. The amounts of IPTG added to the top soft 
agar in each experiment was adjusted to obtain the best result. The results (Figures 3.6-3.8) show 
that the addition of 6XHis tag, MBP or GST to the N-terminus of gpI or gpL has little effect on 
the biological activity of the target protein. However, the addition of any of the three tags to the 
N-terminus of gpK abolishes its ability to complement in vivo. 
3.4.3 Expression of λ gpI 
gpI is a protein with 223 amino acids. A 6XHis tag, MBP or GST was added to the N-terminus 
of gpI. Unfortunately, the yield for each recombinant protein was too low to be detected on SDS-
PAGE by coomassie blue stain. An example of the time-course expression of MBP-I is shown in 
Figure 3.9. Although MBP is expressed in large amounts, the MBP-I fusion protein is not 
detectable on SDS-PAGE by coomassie blue stain. In order to improve the yield of gpI, several 
approaches were tried. 
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Table 3.5 Description of the plasmids used in the spot complementation assay. 
 
Each tag (6XHis tag, MBP or GST) was added to the N-terminus of the target proteins. 
Plasmid Vector Tail proteins 
pLtail pET21+ Wildtype gpJ, gpI, gpL, gpK 
pTQ30 pTQ30 None 
pTQ30-I pTQ30 6XHis tagged gpI 
pTQ30-L pTQ30 6XHis tagged gpL 
pTQ30-K pTQ30 6XHis tagged gpK 
pLC3 pLC3 None 
pLC3-I pLC3 MBP-I 
pLC3-L pLC3 MBP-L 
pLC3-K pLC3 MBP-K 
pGEX-6p-1 pGEX-6p-1 None 
pGEX-6p-1-I pGEX-6p-1 GST-I 
pGEX-6p-1-L pGEX-6p-1 GST-L 
pGEX-6p-1-K pGEX-6p-1 GST-K 
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Figure 3.6 Determination of the biological activity of 6XHis tagged proteins. 
 
BL21(DE3)-△tail was used as the host strain. The spot complementation assay was performed 
as described previously. No IPTG (second column) or 0.01 mM IPTG (third column, except for 
pLtail which contains 1 mM IPTG) is present in the top soft agar.  
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Figure 3.7 Determination of the biological activity of the MBP fusion proteins. 
 
BL21 StarTM(DE3) (Invitrogen) is an E. coli strain designed for improving protein yield in a T7 
promoter-based expression system. Transcription from the T7 promoter is not coupled to 
translation in E. coli since the amounts of mRNA synthesized by T7 RNA polymerase are much 
more than those by E. coli RNA polymerases. This causes the unprotected mRNA to be easily 
degraded by endogenous RNases. This strain contains a mutation in the gene encoding RNaseE 
(rne131), one of the major sources for this mRNA degradation, and therefore improves the 
stability of mRNA transcripts and increases protein expression yield from T7 promoter-based 
vectors. This strain was used as the host for pLC3 based plasmids. The experiment was 
performed as described previously. No IPTG (second column) or 0.2 mM IPTG (third column, 
except for pLtail which contains 1 mM IPTG) was added to the top soft agar. 
 
 
 
 
 
 
 
 
 
 
 89
 
 
 
pLtail 
 
 
pLC3 
 
 
pLC3-I 
 
 
 
 
 
 
pLtail 
 
 
pLC3 
 
 
pLC3-L 
 
 
 
 
 
 
pLtail 
 
 
pLC3 
 
pLC3-K 
Plasmid                     No IPTG                             IPTG                       Phage 
 
 
 
I838 no gpI 
 
 
 
 
 
 
 
 
 
 
 
 
L756 no gpL 
 
 
 
 
 
 
 
 
 
 
 
 
K768 no gpK 
 
 
 
(a) 
(b) 
(c) 
 90
Figure 3.8 Determination of the biological activity of the GST fusion proteins. 
 
BL21(DE3)-Δtail was used as the host strain. Except for pLtail which contains 1 mM IPTG in 
the top soft agar, no inducer was added to the remaining plasmids since the recombinant proteins 
complement best in the absence of inducer. As an alternative, each target plasmid was also tested 
for its ability to complement λcI857 (cI857), a type of phage which differs from the wildtype λ 
phage in that it carries a ts mutation in gene cI. This phage behaves like the wildtype phage in the 
complementation assay. 
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Figure 3.9 Time-course expression of MBP and MBP-I. BL21StarTM(DE3) with the appropriate 
plasmid was used for protein expression. Cells was grown at 37℃ until they reached about 
4X108 cell/ml. IPTG was added to a final concentration of 1 mM to induce protein expression at 
37℃. 100 μl sample was taken at 0 minute, 1 hour, 2 hours and 2.5 hours after induction. 
Subsequently, the samples were prepared for 15% SDS-PAGE and visualized by coomassie blue 
stain. Arrow indicates the position where the MBP-I fusion protein is supposed to be. 
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(1) Toxicity of the protein 
After induction, cells with plasmid encoding recombinant gpI do not grow as well as cells with 
the empty vector. This suggests that gpI may be toxic to E. coli cells. In order to provide more 
stringent control of gene expression, pLysE is used instead of pLysS. Cells with pLysE produce 
higher amounts of T7 lysozyme than those with pLysS and therefore provide tighter control. 
Time-course expression of the recombinant gpI was conducted. However, there is little 
improvement in the yield of gpI (data not shown since the result looks the same as the one using 
pLysS). 
 
(2) Rare codons  
Codons that correspond to rare tRNAs are the least used codons in E. coli. An excess of any of 
these codons may cause problems during translation and thus a reduction in quantity of the 
protein produced. One solution is to use a host strain which contains a plasmid with the 
appropriate tRNA. Gene I contains several rare codons, such as AGA, CGA and AUA. I wanted 
to examine if the low expression level of gpI is due to the presence of the rare codons. If the poor 
yield of gpI is due to the presence of rare codons, an improvement in the yield of the protein will 
be obtained when the rare tRNAs are supplied. Otherwise, no improvement will be observed. 
 
RosettaTM 2 (Novagen) is a derivative of BL21, which supplies rare tRNAs for seven codons, 
AUA, AGG, AGA, CUA, CCC, GGA, and CGG. The target plasmid was transformed into this 
host strain. Compared to the yield of gpI using BL21(DE3)-Δtail as the host strain, there is no 
improvement in the yield of this protein when expressed in strain RosettaTM2 (Figure 3.10). This 
suggests that the low expression level of gpI is not due to the presence of rare codons. 
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Figure 3.10 Time-course expression of GST-I in RossetaTM2. The time-course expression of 
6XHis-tagged gpI, MBP-I and GST-I was performed, but only the result for GST-I fusion protein 
is shown here. BL21(DE3)-Δtail with the appropriate plasmid was used for protein expression. 
The experiment was carried out as described previously (Figure 3.9). Instead of adding 1 mM 
IPTG, 0.4 mM IPTG was added to induce protein expression. The samples were loaded to 15% 
SDS-PAGE and visualized by coomassie blue stain. Arrow indicates the position where the 
GST-I fusion protein is supposed to be.  
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(3) Stability of the mRNA 
One possible reason for the low yield of gpI is that the mRNA is not stable. This is because 
theoretically MBP or GST has its own translational start site and should be translated efficiently 
even if gpI is not translated well. However, in my experiments, I could not detect any MBP or 
GST on SDS-PAGE by coomassie blue stain when they are fused to gpI. When I looked at the 
original DNA sequence of gene I, I noticed that there is a sequence after the terminator of gene I 
which forms a secondary structure. It is likely that this secondary structure is required for the 
stability of mRNA. In order to find out if this is true, this sequence was added after the 
terminator of gene I in the pGEX-6p-1-I construct. However, I did not observe any change in the 
yield of the protein (data not shown). So far, I still do not know how to improve the yield of gpI.  
 
(4) Stability of the protein 
It is possible that the low yield of gpI is due to the instability of the protein. A pulse-chase 
experiment (see MATERIAL AND METHODS) was performed to investigate the stability of 
MBP-I. Figure 3.11 shows that over 50% of radiolabeled MBP-I is degraded within 10 minutes 
and over 90% of the protein is degraded 40 minutes after being synthesized. This indicates that 
the MBP-I fusion protein is not stable and subject to being degraded. Attempts to stabilize gpI by 
co-expressing it with gpJ are desrcribed below in section 3.4.6. 
3.4.4 Expression and purification of λ gpL 
(1) Expression and purification of gpL by 6XHis tag 
The wildtype gpL contains 232 amino acids. At first, I labeled it with a 6XHis tag by cloning 
gene L into the pTQ30 vector. The polyhistidine tagged gpL is expressed in large amounts and  
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Figure 3.11 MBP-I is subject to degradation after being synthesized. 
 
BL21StarTM(DE3)pLysS with pLC3-I was grown in M9-MC medium at 37℃ until it reached 
about 3X108 cell/ml. IPTG (1 mM) was added to induce protein expression. About 30 minutes 
later, rifampicin (200 μg/ml) was added to shut down host strain protein expression. After 20 
minutes, 1 μl (10 mCi/ml) 35S-Met was added for 30 seconds. Subsequently, about 1000-fold 
excess of cold methionine was added. Samples were taken at 0, 2, 5, 10, 15, 20, 30, 40, 50 and 
60 minutes after the addition of cold methionine. The samples were concentrated by TCA 
precipitation before they were prepared for 15% SDS PAGE and visualized by autoradiography. 
 
(a) Lanes 1-10: samples taken at 0, 2, 5, 10, 15, 20, 30, 40, 50 and 60 minutes after the addition 
of cold methionine. 
 
(b) The net intensity of MBP-I band was quantified. The percentage of radiolabeled MBP-I was 
plotted against time after addition of cold methionine. The percentage of the radiolabeled fusion 
protein right before the addition of cold methionine (0 minute) is set to 100%. 
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most of the recombinant protein is soluble (Figure 3.12 lanes 12-13). The 6XHis tagged gpL was 
first purified by nickel affinity chromatography (see MATERIALS AND METHODS) and the 
result is shown in Figure 3.12. Under the experimental conditions, most of the 6XHis-tagged gpL 
is present in elution fractions. There are small amounts of some other contaminant proteins 
which co-elute with the recombinant protein. Several different buffer conditions were tried with 
only a very slight improvement in the purity of the target protein (data not shown). Several other 
purification methods, such as ion-exchange chromatography, were tried to further purify the 
polyhistidine tagged gpL, but there is only a very slight improvement in the purity of the protein 
(data not shown). In addition, I noticed that the nickel column turns to grey after loading the 
sample containing 6XHis tagged gpL. The elution fraction which has the deepest color contains 
the highest concentration of gpL. This suggests that the cysteine residues in gpL may react with 
the nickel ion. Therefore, I decided to switch to MBP fusion to purify gpL. 
 
(2) Purification of gpL by MBP fusion 
MBP-L can complement as well as the wildtype gpL in vivo. This fusion protein was expressed 
at 37℃ and the purification result is shown in Figure 3.13. Panel (a) shows the result for the 
purification of MBP-L by amylose affinity chromatography. Most of the fusion protein is present 
in the elution fractions. Although the fusion protein is not very pure after amylose column 
purification, I decided to try to do the cleavage reaction. The purified MBP-L was incubated with 
AcTEV Protease to cleave MBP from gpL. The result shows that the cleavage reaction is not 
complete (Panel b lane 1). When the digestion mixture was loaded onto the hydroxyapatite 
chromatography to remove maltose, the amount of cleaved gpL in the elution fraction is greatly 
decreased (Panel b lane 2). The elution fraction from the hydroxyapatite chromatography was 
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Figure 3.12 Purification of 6XHis tagged gpL by nickel affinity chromatography. BL21(DE3)-
Δtail pLysS with pTQ30-L was grown in LB with antibiotics at 37℃ until it reached about 
4X108 cell/ml. IPTG (0.4 mM) was added to induce protein expression for 2.5 hours. 
Subsequently, cells were chilled, harvested and resuspended in 1Xbinding buffer (20 mM 
imidazole, 0.5 M NaCl, 20 mM Tris-HCl pH 7.9). Cells were lysed by sonication and the 
supernatant was separated from the pellet by centrifugation at 13,000 RPM for 20 minutes at 4℃. 
The supernatant was loaded onto a nickel column for purification (see MATERIALS AND 
METHODS). The concentrations of imidazole used in the binding and wash buffers are 20 mM 
and 80 mM, respectively. No reductant was added in the buffers used in this experiment. 
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Figure 3.13 Purification of gpL by MBP fusion. 
 
BL21StarTM(DE3) pLysS with pLC3-L was grown in LB with 0.2% (W/V) glucose and 
antibiotics at 37℃ until it reached about 4X108 cell/ml. IPTG (1 mM) was added to induce 
protein expression. About 2.5 hours later, cells were chilled on ice, harvested and resuspended in 
the column buffer (20 mM Tris-HCl pH 7.4, 200 mM NaCl, 1 mM EDTA, 1 mM DTT). Cells 
were lysed by sonication and the pellet was removed by centrifugation at 10,000 RPM for 20 
minutes at 4℃. The supernatant (Panel a lane 2) was used for amylose affinity chromatography 
as described in the MATERIALS AND METHODS. Since the wildtype gpL has 8 cysteines, all 
the buffers used contains 1 mM dithiothreitol (DTT) to prevent the formation of disulfide bonds. 
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reloaded onto the amylose column to separate gpL from MBP and uncleaved MBP-L. However, 
the majority of gpL co-elutes with MBP and MBP-L (Panel b). Several different purification 
methods, such as ion exchange chromatography and gel filtration, were tried (data not shown). 
But, most gpL is either precipitated during purification or co-elutes with MBP and MBP-L.  
 
(3) Purification of gpL by GST fusion 
Due to the difficulty of the removal of MBP and MBP-L from gpL, I tried to purify gpL by GST 
fusion and the result is shown in Figure 3.14. GST-L is expressed in large amounts in a soluble 
form at 37℃ (lane 2). Early attempts to purify GST-L suggest that the bacterial Hsp70, DnaK, 
co-elutes with it (data not shown). In order to dissociate the complex, the crude lysate was first 
incubated with ATP and Mg2+ at 37℃ for 20 minutes. After removal of pellet by centrifugation, 
the supernatant was loaded onto the Glutathione Sepharose chromatography for purification. 
About 60-70 mg of the fusion protein can be purified from 1 liter culture. The result shows that 
there are several minor proteins co-purified with GST-L (lane 3). The minor bands disappear 
after digestion by PreScission Protease (lane 4), suggesting that they may be degradation 
products of GST-L. The digestion mixture was reloaded onto the Glutathione Sepharose 
chromatography. Lanes 5-8 shows that the cleaved gpL is present in the flow through fractions 
while GST is in the elution fractions. 15-20 mg of cleaved gpL can be obtained from 60-70 mg 
of the purified fusion protein. This protein has been sent to our collaborators for structural 
studies. 
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Figure 3.14 Purification of gpL by GST fusion. 
 
BL21(DE3)-△tail is used as the host strain. Cells containing the target plasmid were grown at 
37℃ until they reached about 4X108 cell/ml. IPTG (1 mM) was added to induce protein 
expression at 37℃ for 2.5 hours (or cells can be induced with 0.4 mM IPTG at 28℃ overnight). 
After this, the culture was chilled on ice, harvested and resuspended in Buffer 1 (50 mM Tris-
HCl pH 8.0, 200 mM NaCl, 1 mM EDTA, 0.1% Triton X-100, 1mM DTT). Cells were broken 
down by sonication and the lysate was incubated with ATP and Mg2+ before it was centrifuged 
to remove the pellet. The supernatant was used for Glutathione Sepharose affinity 
chromatography as described in MATERIALS AND METHODS. The 1X wash buffer used in 
this experiment contains 0.5% Triton X-100. However, the buffers used for the Glutathione 
Sepharose chromatography to separate gpL from the cleavage mixture do not contain any 
detergent. All the buffers used contain 1 mM DTT. 
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3.4.5 Expression and purification of λ gpK 
(1) Expression of the recombinant protein 
The gene K of phage lambda encodes a 199-amino-acid sequence. When it is labeled with a 
6XHis tag at the N-terminus, the yield of this protein is too low to be used for purification (data 
not shown). The GST-K fusion protein is expressed in large amounts. However, the majority of 
the protein is insoluble. Different expression temperatures (37℃, 30℃ and 26℃) and buffer 
conditions (such as presence or absence of detergents) have been tried with no improvement in 
the solubility of the protein (data not shown). 
 
In terms of the MBP fusion protein, most of MBP-K is insoluble when it is induced at 37℃ with 
1 mM IPTG (Figure 3.15). However, when the growth temperature is lowered, more fusion 
protein becomes soluble. When the temperature is reduced to 26℃, most of the fusion protein 
made is soluble. The purification of MBP-K fusion will be described below. 
 
(2) Purification of gpK by MBP fusion 
The fusion protein was expressed as described above. Figure 3.16 shows the purification result. 
70-85 mg of the fusion protein can be purified from 1 liter culture. Several other proteins co-
elute with MBP-K (Panel a). In order to further purify the fusion protein, ammonium sulfate 
precipitation was performed. The result shows that most of the fusion protein precipitates 
between 60-70% saturated ammonium sulfate (Panel b). Subsequently, the purified MBP-K 
fusion protein was digested by AcTEV Protease. The digestion reaction is not complete (Panel c 
lane 2). When this mixture was loaded onto the hydroxyapatite chromatography to remove  
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Figure 3.15 The effect of temperature during expression on the solubility of MBP-K. 
 
BL21 StarTM(DE3) was used as the host strain. The culture was grown at different temperatures 
until they reached about 4X108 cell/ml. IPTG was added to induce protein expression. 
Subsequently, cells were chilled on ice, harvested and resuspended in the column buffer. After 
lysis by sonication, the pellet was removed from the supernatant by centrifugation at 10,000 
RPM for 20 minutes at 4℃. The pellet was resuspended in the same volume of the column buffer 
as the supernatant. Finally, the supernatant and pellet was prepared for 15% SDS-PAGE and 
visualized by coomassie blue stain. 
 
Lanes 1-2: The culture was grown at 30℃ before induction. At the time of adding 0.4 mM IPTG, 
the temperature was switched to 26℃ overnight.  
 
Lanes 3-4: The culture was grown at 30℃. When cells reached the right density, 1 mM IPTG 
was added to induce protein expression for 3.5 hours at 30℃.  
 
Lanes 5-6: The culture was grown at 37℃ and induced with 1 mM IPTG for 2.5 hours at the 
same temperature. 
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Figure 3.16 Purification of gpK by MBP fusion. 
 
(a) The supernatant from the culture induced at 26℃ was used for amylose affinity 
chromatography purification (see MATERIALS AND METHODS) and the elution fractions are 
shown.  
 
(b) Ammonium sulfate precipitation was performed to further purify MBP-K fusion protein. 
Proteins that were pelleted by ammonium sulfate at different concentrations are shown. 
 
(c) The purified protein was cleaved by AcTEV Protease and the result is shown in lane 2. After 
this, the cleavage mixture was loaded onto the hydroxyapatite chromatography to remove 
maltose. The elution fraction (lane 3) was reloaded onto the amylose affinity chromatography to 
purify gpK and the result is shown in lanes 4-7. No DTT is present in the buffers used for 
purification. 
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 maltose, 80-90% of gpK is lost due to precipitation (Panel c lane 3). The elution fraction was 
reloaded onto the amylose affinity chromatography to purify gpK from the other components. 
However, like cleaved gpL from MBP-L, the cleaved gpK co-elutes with MBP and uncleaved 
MBP-K. Several other purification methods, such as ion-exchange chromatography, DEAE-
Sepharose chromatography and gel filtration, have been tried. But, the majority of gpK is either 
lost possibly due to its precipitation on the top of the column or co-eluted with MBP and MBP-K 
possibly due to the incompelete cleavage of the fusion protein. 
3.4.6 Co-expression of the λ tail tip proteins 
As shown above, I have had some trouble in the solubility of gpJ and in the expression of gpI. It 
is possible that some tail proteins may need to be co-expressed in order to obtain a stable or 
soluble form of the protein. In order to examine if this is true, I cloned the target genes into the 
high expression plasmid pGEX-6p-1 and tried four different co-expression experiments: (1) gpJ 
and GST-I, (2) gpJ, gpI and GST-K, (3) gpI and GST-K, (4) gpI, gpK and GST-L. Although gpJ 
alone is expressed in large amounts in an insoluble form, no tail proteins are observed in the 
SDS-PAGE by coomassie blue stain when gpJ is co-expressed with GST-I (data not shown). 
When gpJ is co-expressed with gpI and GST-K, most of gpJ is insoluble (data not shown). In 
terms of the remaining two constructs (gpI and GST-K or gpI, gpK and GST-L), only the protein 
with the tag has a good yield and can be detected on SDS-PAGE by coomassie blue stain. The 
other tail protein(s) in the construct can not be detected in the crude lysate or purified complex 
(data not shown).  
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3.5 DISCUSSION 
3.5.1 Comparisons of the different purification systems 
Three different tags were used in the above experiments to facilitate protein purification. The 
main advantage of polyhistidine tag is that it is very small and therefore can minimize the effect 
of additional sequence on the activity of the target protein. However, the yield of some proteins 
is low and this may not be improved by simply adding a polyhistidine tag. MBP or GST fusion 
can sometimes solve this problem since they have their own translational start site. Besides, the 
MBP or GST fusion can sometimes help improve the solubility and stability of the target protein. 
The main disadvantage for these two systems is that the tag is large and therefore they may 
impair the activity of the target protein. 
3.5.2 The solubility of the λ tail tip complex 
As shown above, the majority of the tail tip complex is insoluble, which makes the purification 
impractical. The early studies for the in vitro complementation assays between different tail-
defective lysates suggest that the tail tip complex must be soluble to some extent. This 
disagreement can be explained by two possible reasons. First, the conditions for sample 
preparation are different. For samples prepared for purification, the lysates are centrifuged much 
harder than those used for in vitro complementation assays. Besides, the buffer conditions are 
also different. Second, it is possible that only a small fraction of the tail tip proteins is soluble 
and this amount is enough for the in vitro complementation assay. The results from Chapter 4 
also imply that the amounts of the tail tip proteins required for the in vitro complementation 
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assay is very small. If this is true, it may be that lambda tail assembly initiates at the cell 
membrane and then continues to assemble in the cytoplasm. 
3.5.3 Expression and purification of λ tail tip proteins 
In my experiments to date, gpJ and gpI have presented the most intractable problems for 
purification due to their insolubility and for gpI, instability. GpL has been the easiest to work 
with, and this has lead to a successful purification. gpK has been intermediate in these regards, 
showing good purification as the MBP fusion protein, but poor recovery after cleavage from 
MBP. GpK would seem to be an alternative target for future attempts to carry forward the 
purification to tail tip proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 113
4.0 DETERMINATION OF THE COMPOSITION AND STOICHIOMETRY OF THE 
LAMBDA TAIL TIP COMPLEX 
4.1 INTRODUCTION 
The assembly of λ tail tip is controlled by at least four proteins. The order of the interactions 
among these proteins has been known for many years (Figure 1.5). However, little is known 
about the composition, stoichiometry and detailed structure of the tail tip. There are several 
different ways of addressing these questions. A fundamental approach is to isolate the tail tip 
complex, separate it into its components by denaturing gel electrophoresis, and quantify the 
relative amounts of the protein components by densitometry. The copy numbers of gpJ, gpH and 
gpV have been determined in a similar way (Casjens and Hendrix, 1974). The composition can 
be related to the structure of the complex if X-ray structures of individual proteins can be fit into 
the cryo-EM density of the tail tip. The arrangement of subunits in the T4 baseplate has been 
determined by this method (Rossmann et al., 2001; Rossmann et al., 2004). In Chapter 3, I 
described attempts to purify the tail tip complex and the individual tail tip proteins for structural 
studies, but the success of this work to date has been only the purification of gpL.  
 
In this chapter, I tried to determine the composition and stoichiometry of the tail tip complex 
which were prepared by several different methods.  
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4.2 PRECIPITATION OF λ TAIL TIP ASSEMBLY INTERMEDIATES BY E. COLI 
CELLS 
One crude way of examining the compositions and stoichiometries of the tail tip assembly 
intermediates is to precipitate them from E. coli cells followed by SDS-PAGE, autoradiography 
and densitometry. This method depends on the specific interaction between the λ gpJ tail fiber 
protein and the λ receptor, LamB, on the surface of E. coli (Tsui and Hendrix, 1983). The pIam, 
pLdel, pKam6 and pLtail plasmids were previously described in Table 3.1. The tail tip proteins 
expressed from these plasmids were radiolabeled (see MATERIALS AND METHODS). After 
lysis, the lysate was incubated with E. coli cells to allow the binding of the tail fiber to the LamB 
receptor. Subsequently, cells were washed three times with λ dil to remove the unbound 
components and the samples were prepared for SDS-PAGE followed by autoradiography and 
densitometry. A strength of this approach is that all tail tip assembly intermediates are expected 
to be precipitated, because gpJ is the first protein in the assembly pathway. In this experiment, E. 
coli cells will precipitate any complexes containing gpJ, including assembled structures as well 
as any partially assembled structures. Therefore, the stoichiometries of the proteins may be 
distorted toward over-representation of components that add early in the assembly pathway.  
 
Figure 4.1 is the result of this experiment and Table 4.1 shows the copy numbers of the tail tip 
proteins in the complex quantified from Figure 4.1. The result (lane 2) indicates that in the 
absence of gpI, a very small amount of gpL can assemble onto gpJ. In contrast, the absence of 
gpL does not seem to affect the assembly of gpI (lane 4). These results agree with the in vitro 
complementation data, which indicate that gpI precedes gpL in the assembly pathway. In the  
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Figure 4.1 Precipitation of λ tail tip assembly intermediates by E. coli cells. 
 
The pLtail plasmid encodes all four proteins required for lambda tail tip assembly. The pIam, 
pKam6 and pLdel are derivatives of pLtail and carry an amber mutation in gene I (pIam) or gene 
K (pKam6), or a deletion in gene L (pLdel). The detailed information about these plasmids was 
described in Table 3.1.  The plasmids were co-transformed with pLysS into BL21(DE3)-△tail. 
Tail proteins expressed from the plasmids were radiolabeled and lysed (see MATERIALS AND 
METHODS). The samples were incubated with E. coli cells for 1 hour or overnight at 4℃ 
before they were washed with λ dil to remove the unbound components. The bound proteins 
were prepared for 15% SDS-PAGE. The gel was dried and visualized by autoradiography.  
 
Plasmids used in this experiment:  
Lane 1: pET21+ (empty vector) 
Lane 2: pIam (I-, encodes gpJ, gpL and gpK) 
Lane 3: pKam6 (K-, encodes gpJ, gpI and gpL) 
Lane 4: pLdel (L-, encodes gpJ, gpL and gpK) 
Lane 5: pLtail (complete, encodes gpJ, gpI, gpL and gpK) 
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Table 4.1 Stoichiometries of λ tail tip proteins in the samples precipitated by E. coli cells. 
 
The experiment shown in Figure 4.1 was repeated twice. The SDS-PAGE was exposed to films 
for different times (For example: 1 hour, 2 hours, 3 hours and 6 hours). The films were then 
scanned and analyzed as described in MATERIALS AND METHODS. The copy numbers of gpI, 
gpL and gpK were corrected for the number of sulfur atoms in the proteins and normalized to 3 
copies of gpJ. The copy numbers were rounded to the nearest integers.  
 pIam pKam6 pLdel pLtail 
gpJ 3 3 3 3 
gpI  3-5 3-4 2-3 
gpL ~1 2-3  2-4 
gpK    <0.6* 
 
* The band of gpK examined is the gpK-like band shown in Figure 4.1. The intensity of the gpK-
like band is obtained by subtraction of the net intensity of the gpK-like band in lane 3 from that 
of lane 5. 
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absence of gpK, the other three proteins appear to be present in amounts similar to the situation 
when it is present. This again agrees with the in vitro complementation data, which say that gpK 
acts after gpJ, gpI and gpL. There is a very faint band which migrates about the same position as 
gpK in lanes 2-5 (Figure 4.1). The fact that the band is also present in the lysate in which there is 
an amber mutation early in gene K shows that this band is not gpK. This band could possibly 
obscure small amounts of gpK in other lysates. Therefore, it is not clear whether or not gpK is 
present in the tail tip assembly intermediates from this experiment, but it is clearly not present in 
amounts comparable to the other tail proteins. In fact, the amount of material in the gpK position 
indicating the contaminant band amounts to less than one molecule per structure. The absence of 
a gpK band in the K-, L- and I- lanes of the gel in Figure 4.1 is not unexpected, in the case of the 
K- lane because of the K amber mutation and in the cases of the L- and I- lanes because I and L 
precede K in the assembly pathways. Its absence in the pLtail plasmid lane is unexpected. 
Possible explanation include: 1) gpK is not efficiently assembled into the complex in these 
conditions, 2) it is assembled but dissociates in the in vitro conditions, or 3) it is assembled but is 
proteolytically processed or degraded. An unknown band, xx2, which has a mobility 
corresponding to about 14 kDa, is only detected in the sample from pLtail plasmid. It is not clear 
if it is a processed or degradation product of one of the tail proteins. The intensity of the gpI band 
in this sample is reduced relative to the other samples where it is present, suggesting that band 
xx2 may be a fragment of gpI. Alternatively, it could be a fragment of gpK. 
 
A striking feature of the gel in Figure 4.1 is the band labeled xx1 with a mobility corresponding 
to about 16 kDa. This is apparently not one of the phage-encoding proteins, or a processed form 
of one of them, because it is present in the lanes with I, K and L mutations as well as in the intact 
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pLtail lane. It is also not derived from the experimental plasmid since it is absent in the empty 
vector lane. It may be a cellular protein that associates stably with gpJ. If we assume an average 
sulfur content for this protein (the sulfur content in the protein corresponding to band xx1 is the 
same as that of λ gpJ), it is present in about 8-12 copies for each 3 copies of gpJ. It has not been 
possible to attempt further identification of this protein because it is not available in biochemical 
scale quantity. 
4.3 CHARACTERIZATION OF λ TAIL TIP BY SUCROSE VELOCITY GRADIENT 
There are two main drawbacks to the technique described in the previous section. First, E. coli 
cells will precipitate assembled structures as well as any partially assembled structures. Thus, the 
stoichiometries of the tail proteins may be distorted. Second, there is no way to determine the 
biological activity of the tail tip proteins. To solve this, sucrose gradient was used to separate 
lambda tail tip complex followed by in vitro complementation assay to examine the biological 
activity of the tail proteins in each fraction. The fractions from the gradient were further assayed 
by co-immunoprecipitation (Co-IP) followed by SDS-PAGE, autoradiography and densitometry 
to determine the compositions and stoichiometries of the fractions from the gradient. So, this 
experiment is able to determine if the tail tip proteins in the complex have any biological activity. 
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4.3.1 Construction of biologically active T7-tagged gpL 
The pGtail plasmid encodes the first 8 proteins involved in lambda tail assembly. This plasmid 
was chosen instead of pLtail because the crude lysate from pGtail shows much better in vitro 
complementation activity than that of pLtail.  
 
A T7 tag was added to the N-terminus of gpL and the new plasmid was called pGtail-LT7. The 
spot complementation assay was performed to determine the ability of the recombinant protein to 
complement λcI857 and λLam756cI857.  Table 4.2 lists the plasmids used in this assay. Figure 
4.2 shows that the recombinant protein can complement as well as the wild type protein, 
suggesting that the addition of T7 tag has little effect on the biological activity of gpL in vivo. 
4.3.2 Separation of λ tail tip complex by sucrose velocity gradient 
λ tail proteins expressed from pGtail-LT7 plasmid were radiolabeled by 35S-Met and prepared 
for 10-25% sucrose gradient (see MATERIALS AND METHODS). After centrifugation in an 
SW60 rotor at 58,000 RPM for 3.5 hours at 4 , the centrifuge tube was punctured at the bottom ℃
and the sucrose gradient collected into 12 fractions. Each fraction was examined by in vitro 
complementation assay and co-immunoprecipitation.  
 
(1) In vitro complementation assay 
This assay is aimed to determine the biological activity of the tail tip proteins in the fractions 
from the gradient. Figure 4.3 is an illustration of the experimental design. The lysogen which is 
not able to make tails due to an amber mutation in one of the tail genes is used to make  
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Table 4.2 Plasmids used in the spot complementation assay. 
Plasmid Vector used Protein expressed Description 
pET21+ pET21+ None Empty vector 
pGtail pET21+ gpJ, gpI, gpL, gpK, 
gpM, gpG, gpGT, 
gpH 
Wildtype genes J, I, L, K, M, G, 
T and H were introduced into 
pET21+ vector 
pGtail-LT7 pET21+ gpJ, gpI, T7-tagged 
gpL, gpK, gpM, 
gpG, gpGT, gpH 
Differs from pGtail in that it 
encodes gpL with a T7 tag at the 
N-terminus 
 
Note: The sequence of T7 tag added to gpL is MASMTGGQQMG. 
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Figure 4.2 The T7-tagged gpL is biologically active. 
 
The target plasmids were co-transformed with pLysS into strain BL21(DE3)-Δtail. They were 
spotted with λcI857 (cI857) and λLam756cI857 (L756). The first column is the plasmids being 
tested. No IPTG (second column) or 1 mM IPTG (third column) is present in the top soft agar. 
The fourth column shows the type of phage spotted and the defect in each phage. Each row was 
spotted with 10-fold decrease in number of phages from left to right with the left-most spot 
having about 4X105 phages. 
 
(a) pET21+ is an empty vector and produces no tail proteins.  
 
(b) pGtail encodes the first 8 proteins involved in lambda tail assembly.  
 
(c) pGtail-LT7 differs from pGtail in that it encodes a T7-tagged gpL.  
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Figure 4.3 Schematic diagram of the in vitro complementation assay. 
 
A lysogen which contains lambda phage with an amber mutation in one of the tail genes is used 
to make concentrated tail-defective lysate. A small sample is taken from each of the sucrose 
gradient fractions and added to the tail-defective lysate. The mixture is frozen in liquid nitrogen 
for 10 seconds and then sits at room temperature overnight. Subsequently, the mixture is diluted 
by λ dil containing 10 μg/ml DNase to stop the reaction. Plaque assay is performed to determine 
the phage titer in the mixture. If tail proteins in the fractions from the gradient are able to 
complement the tail-defective lysate, an increase in the phage titer over the background titer will 
be observed. The complementation efficiency (C.E.) is expressed as the ratio of 
complementation phage titer to the background phage titer. The complementation efficiency is 
concentration dependent. In order to get better complementation efficiency, the tail proteins in 
both samples have to be very concentrated. In addition, the pH of the samples should be kept 
above 7 due to the poor in vitro complementation activities for most λ tail precursors at pH 
below 7.  
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concentrated tail-defective lysate. The lysate is then mixed with the fractions collected from the 
gradient. The mixture is frozen in liquid nitrogen for a short time to lyse the cells and then 
incubated at room temperature overnight. Subsequently, λ dil with 10 μg/ml DNase is added to 
stop the reaction and the mixture is used for plaque assay to determine the phage titer in the 
reaction. If the tail tip proteins in the fraction are able to complement the tail-defective lysate, an 
increase in the phage titer over the background phage titer will be observed. 
 
Figure 4.4 shows that the fifth fraction has the highest phage titer and the phage titer for most of 
the other fractions is close to the background phage titer. Therefore, the majority of the 
complementation activity is present in the fifth fraction. 
 
(2) Co-immunoprecipitation 
This assay is to determine the composition of the material that co-precipitates with gpL-
presumably including tail assembly complexes- from each of the fractions from the sucrose 
gradient. Each fraction from the sucrose gradient was prepared for Co-IP by anti-T7 antibody 
(see MATERIALS AND METHODS). After this, the samples were prepared for SDS-PAGE and 
visualized by autoradiography. Figure 4.5 shows that the majority of the tail tip proteins appear 
near the top of the gradient. Based on the data in Figures 4.4-4.5, it can be concluded that the tail 
tip proteins in the fraction which contains most of the in vitro complementation activity only 
constitutes a very small fraction of the tail tip proteins in the lysate. Most of the tail tip proteins 
are near the top of the gradient and are not biologically active in this complementation assay. 
Besides, the net intensity of the tail tip protein bands in the fraction which has most of the in 
vitro complementation activity is similar to that of the surrounding fractions. This may indicate  
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Figure 4.4 The majority of the in vitro complementation activity appears in the fifth fraction 
from the sucrose gradient. 
 
Lysogens 594(λJam442cI857), 594(λIam838cI857), 594(λLam756cI857) and 
594(λKam768cI857) were used to make tail-defective lysates. Fractions from sucrose gradient 
were complemented with the tail-defective lysates. The phage titer in each reaction was 
examined by plaque assay. The phage titer was plotted against the fraction number. If a fraction 
is able to complement J--lysate, it will be said that it has J+ activity and similarly for I+ or L+ 
activity. Due to the high background phage titer in the K--lysate (about 108 PFU/ml in the 
concentrated lysate), it is hard to tell if there is an increase in the phage titer in the reaction. So, 
the complementation activity for K--lysate is not shown here. 
 
Background phage titer:  
J--lysate: 8X103 PFU/ml 
I--lysate: 4.6X105 PFU/ml                
L--lysate: 3.5X105 PFU/ml 
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Figure 4.5 Most of the tail proteins are present in the top fractions from the gradient and are not 
able to complement in vitro. 
 
200 μl of each fraction from the gradient was incubated with diluted anti-T7 antibody on a 
rotating wheel at 4  for 2 hours before the addition of the beads. After overnight incubation ℃
with the beads, the mixture was washed 3 times with Co-IP buffer and resuspended in 40 μl 1X 
SDS sample buffer. The sample was boiled and loaded to 15% SDS-PAGE. 
 
 (a) Lanes 1-12 are fractions 1-12 from the bottom to the top of the gradient. Each fraction was 
prepared by Co-IP using anti-T7 antibody. Lane 13 is the sample used for the gradient. There is a 
very faint of gpK band present in the fifth and sixth fraction. The gpK band is more intensive in 
the fractions without Co-IP (data not shown). 
 
 
(b) The film from Panel (a) was scanned and the net intensity of the bands of interest was 
measured. The net intensity of the bands was plotted against the fraction number. Arrow 
indicates the fraction that contains most of the in vitro complementation activity. 
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that only very small amounts of the tail proteins are involved in the in vitro complementation 
assay; this may explain the notorious inefficiency of the in vitro complementation assay for the 
early steps of assembly. In fact, when I tried to examine the copy numbers of the tail tip proteins 
in the fraction which has in vitro complementation activity (fifth fraction), the bands 
corresponding to gpK and gpI are too weak to be quantified. 
 
In addition to the pGtail-LT7 plasmid, a T7 tag was added to the C-terminus of gpI in the pGtail 
plasmid, resulting in pGtail-IT7. The recombinant protein complements as well as the wild type 
protein in the in vivo complementation assay (Figure 4.6). The experiments for pGtail-LT7 as 
described above were done for the pGtail-IT7 plasmid. The result is comparable to that of the 
pGtail-LT7 plasmid (Figure 4.7). 
 
Band xx3, which migrates about 70 kDa on SDS-PAGE, seems to co-sediment with the tail tip 
complex, and it is co-precipitated with gpL and with gpI in the experiments shown in Figures 4.5 
and 4.7. This experiment was repeated and fractions 4-6 were prepared for Co-IP using either 
anti-DnaK or anti-groEL antibody. Figure 4.8 shows that band xx3 is present in the Co-IP 
samples using anti-DnaK antibody, not in those using anti-groEL antibody. This suggests that 
band xx3 is DnaK. gpK seems to be co-precipitated with DnaK. A very faint gpJ band can be 
found on the original film in lanes 4-9, but it is too faint to be seen in this figure. The presence of 
gpL or gpI is uncertain due to overloading of samples in lanes 10-11. Taken together, these 
results agree that DnaK is a component of a complex of tail tip proteins that co-sediments with 
the in vitro complementation activity of the tail tip proteins. This leads to a suggestion that DnaK 
has a role in tail tip assembly. 
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Figure 4.6 The T7-tagged gpI is biologically active. 
 
The plasmids of interest were co-transformed with pLysS into BL21(DE3)-Δtail. Each plasmid 
was tested for its ability to complement λcI857 (cI857) and λIam838cI857 (I838). No IPTG or 1 
mM IPTG is present in the top soft agar. The complementation assay was performed as described 
(see MATERIALS AND METHODS). 
 
(a) pET21+ is an empty vector and produces no tail proteins.  
 
(b) pGtail encodes the first 8 proteins involved in lambda tail assembly.  
 
(c) pGtail-IT7 differs from pGtail in that it encodes gpI with a T7 tag at its C-terminus.  
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Figure 4.7 The fraction with most of the in vitro complementation activity does not overlap with 
the fraction containing most of the tail tip proteins. 
 
The experimental procedure, including sucrose gradient, in vitro complementation assay and Co-
IP, for the pGtail-IT7 lysate is the same as that for the pGtail-LT7. About 13 fractions were 
collected from the gradient. 
 
(a) Each fraction from the gradient was assayed for its ability to complement J--, I--, L-- and K--
lysates. The phage titer was plotted against the fraction number. The complementation activity of 
K--lysate is not shown here due to the high background phage titer in this lysate. Background 
phage titer: J--lysate: 2.5X104 PFU/ml; I--lysate: 2.3X105 PFU/ml; L--lysate: 1.0X105 PFU/ml. 
 
(b) Lanes 1-13 are samples from the bottom to the top of the gradient. Each fraction was 
prepared by Co-IP using anti-T7 antibody. Lane 14 is the sample used for the gradient. 
 
(c) The film from Panel (b) was scanned and bands of interests were quantified. The net intensity 
of the bands was plotted against the fraction number. Arrow shows the fraction with most in 
vitro complementation activity. 
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Figure 4.8 Band xx3 is DnaK. 
 
Tail proteins expressed from plasmid pGtail-LT7 were radiolabeled and prepared for sucrose 
gradient as described previously. After centrifugation, the gradient was collected into 12 
fractions. Fractions 4-6 were used for co-immunoprecipitation using anti-DnaK or anti-groEL 
antibody. Subsequently, the samples were prepared for 15% SDS-PAGE and visualized by 
autoradiography. 
 
Lanes 1-3: Fractions 4-6 from the sucrose gradient without Co-IP. 
Lanes 4-6: Fractions 4-6 from the sucrose gradient prepared by Co-IP using anti-    
                  groEL antibody. 
Lanes 7-9: Fractions 4-6 from the sucrose gradient prepared by Co-IP using anti- 
                  DnaK antibody. 
Lane 10: Lysate prepared from pKam6 (contains λ tail genes J, I and L) was used as  
                marker. 
Lane 11: Lysate prepared from pT7-5-Vtail (contains λ tail genes V-J) was used as 
               as marker. 
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4.4 SEPARATION OF λ TAIL BY GLYCEROL GRADIENT 
The stoichiometries of the tail tip proteins determined in Section 6.2 are variable and subject to 
uncertainties about whether the complexes being assayed accurately reflect the composition of 
either the tail assembly intermediates or the mature tail. Therefore, I decided to determine the 
stoichiometries of the tail tip proteins in the purified tail. The pEtail4 plasmid encodes all 11 
proteins required for lambda tail assembly. Tail proteins expressed from the plasmid were 
radiolabeled and prepared for velocity sedimentation in a 10-30% glycerol gradient as described 
in MATERIALS AND METHODS. After centrifugation, the tube was punctured at the bottom 
and about 12 fractions were collected. TCA precipitation was carried out to concentrate the 
sample. After TCA precipitation, each fraction was prepared for SDS-PAGE followed by 
autoradiography and densitometry. Figure 4.9 shows that there is a peak at the eighth fraction for 
tail proteins which are present in the mature structure. The amount of gpG increases from the 
bottom to the top of the gradient because gpG acts as a chaperone and is not present in the 
mature tail. Therefore, the majority of the tail is present in the eighth fraction. Table 4.3 is the 
quantification from the eighth fraction. The copies of gpV are a little lower than what has been 
reported probably due to the dramatic difference in the intensity of the two bands, gpJ and gpV. 
The copies of gpL are consistent with what has been shown in Table 4.1. The band intensity of 
gpI and xx4, an unknown band with a mobility corresponding to about 25 kDa, seems to vary 
greatly from individual experiments. In one extreme example, the intensity of the xx4 band is 
almost 1/3-1/2 as intensive as gpV in the glycerol-gradient purified tail prepared from pEtail4-7S 
(This plasmid differs from pEtail4 in that it carries a non-conserved cysteine to serine mutation 
in gpL. The detailed information about the plasmid is described in Chapter 5), and it is very hard  
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Figure 4.9 Separation of lambda tail by glycerol gradient. 
 
The pEtail4 plasmid encodes all 11 proteins required for lambda tail assembly. Tail proteins 
expressed from this plasmid were labeled by 35S-Met and prepared for 10-30% glycerol gradient. 
After centrifugation at 40,000 RPM for 3.5 hours at 4 , the gradient tube was punctured at the ℃
bottom and fractions collected. The fractions were then prepared for 15% SDS-PAGE and 
visualized by autoradiography. In this experiment, proteins / protein complexes will go to 
different positions of the gradient according to their sedimentation coefficient. Most 
unassembled proteins will remain in the top of the gradient. 
 
(a) Lanes 1-12 are fractions 1-12 from the bottom to the top of the gradient. The amount of the 
sample loaded onto lane 12 is 10 times less than those of lanes 1-11. Lane 13 is the sample used 
for the gradient 
 
(b) The net intensity of some tail protein bands was quantified. The net intensity of the bands of 
interest was plotted against the fraction number. 
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Table 4.3 Quantification of λ tail proteins from tails purified by glycerol gradient. 
 
The experiment was repeated twice. The fraction which contains most of the tail was loaded to 
22.5% SDS-PAGE and several different lengths of exposure were made. The bands were 
visualized by autoradiography and examined by densitometry. The copy numbers of the tail 
proteins were normalized to 3 copies of gpJ. 
 Copies of λ tail proteins 
gpJ 3 
gpI 1-3 
gpL 3-4 
gpH 1-3 
gpH* 5-8 
gpV 153-177 
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to detect gpL and gpI bands in this case. It is not clear whether xx4 is a processed or degradation 
product of one of the tail proteins.  
4.5 PURIFICATION OF λ PHAGE BY CESIUM CHLORIDE STEP GRADIENT 
gpH, the unprocessed tape measure protein, is not present in the mature tail. But a small amount 
of gpH is present in the eighth fraction (Figure 4.9). This suggests that the purified tail is a 
mixture of the mature tail and partially assembled tail. In order to solve this problem, I tried to 
determine the stoichiometries of the tail tip proteins from purified lambda phage. In this 
experiment, the tail proteins expressed from pEtail4 were radiolabeled and the cells were lysed 
as described in MATERIALS AND METHODS. The 594(λVam750Sam7cI857) lysogen 
produces λ head without tail attached. This lysogen was used for head preparation (see 
MATERIALS AND METHODS). Excess amount of the purified head were mixed with the 
radiolabeled tail for the head-tail joining reaction (see MATERIALS AND METHODS). After 
this, the phage mixture was loaded onto a cesium chloride step gradient to separate lambda phage 
virions. The tube was punctured at the bottom and about one third of the gradient from the 
bottom was collected after centrifugation. The samples were prepared for SDS-PAGE followed 
by autoradiography and densitometry.  Each fraction from the gradient was also examined by 
plaque assay to determine the phage titer. The result is shown in Figure 4.10 and Table 4.4. Most 
of the phage is present in the fourth fraction.  Fractions 8-13 contain most of the other 
components from the phage mixture, including a small amount of λ phage, tail assembly 
intermediates, unassembled phage proteins and so on. With elongated exposure time, several 
faint bands can be observed (Panel b). gpL behaves a little strangely. The band looks a little  
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Figure 4.10 Purification of lambda phage by cesium chloride step gradient. 
 
λ tail proteins expressed from the pEtail4 plasmid were radiolabeled by 35S-Met. The 
594(λVam750Sam7cI857) lysogen was used asa donor of non-radioactive heads. The head and 
tail were prepared for the head-tail joining reaction as described in MATERIALS AND 
METHODS. Subsequently, the phage mixture was loaded onto the top of two layers of cesium 
chloride solutions with different density (1.4 g/cm3 and 1.6 g/cm3). After centrifugation, the tube 
was punctured at the bottom and about 1/3 from the bottom of the gradient tube was collected.  
 
(a) Each fraction from the gradient was prepared for 15% SDS-PAGE and visualized by 
autoradiography. Lanes 1-13: Fractions 1-13 collected from the bottom to about 1/3 of the 
cesium chloride gradient tube. The film was exposed to the dried SDS gel for 1 day. 
 
(b) The fourth fraction was loaded to 20% SDS-PAGE and the film was exposed to the SDS gel 
for 14 days in order to see the faint bands. 
 
(c) Each fraction from the gradient tube was examined by plaque assay to determine the phage 
titer. The base-10 logarithm of the phage titer in each fraction was plotted against the fraction 
number.  
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Table 4.4 Quantification of lambda tail proteins from purified phage. 
 
The fourth fraction from the gradient was loaded onto 22.5% SDS-PAGE. The film was exposed 
to the gel for different times and visualized by autoradiography. The bands of interest were 
quantified. The copy numbers of gpH* and gpV were normalized to 3 copies of gpJ. These 
numbers are close to the previous studies. The copy numbers of gpL and gpM were normalized 
to 6 copies of gpU. The gpL band is very weak and looks a little fuzzy. Therefore, the 
quantification for this protein may not be accurate.  
 Copies of λ tail proteins in purified phage 
gpJ 3 
gpI  
gpL ~1 
gpM 8 
gpH* 6 
gpV 178 
gpU 6 
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fuzzy possibly due to the presence of 8 cysteine residues. No band is found in the position 
corresponding to gpI. But, a weak band, xx6, which migrates a little slower than gpI is found. 
Another band (xx5) which appears between gpI and gpL, is probably the same one as xx4 found 
in Figure 4.9. So far, it is not clear what these two bands are.  
4.6 DISCUSSION 
4.6.1 gpK may be loosely associated with the complex 
gpK presents a conundrum because it is required for lambda tail assembly, but it is not found in 
the mature structure. The presence of gpK-like band in the sample prepared from the pKam6 
plasmid indicates that it may be a background band which migrates about the same position as 
lambda gpK (Figure 4.1). This suggests that gpK may be loosely associated with the complex. 
There are two experiments which support this hypothesis. In one experiment, 6XHis tag was 
added to the C-terminus of gpI encoded from pLtail. The modified gpI can complement as well 
as the wildtype protein in the in vivo complementation assay. Radiolabeled proteins from this 
plasmid were loaded onto a nickel column. When the immidazole concentration in the wash 
buffer was increased from 90 mM to 120 mM, there is a significant decrease in the amount of 
gpK found in the elution fractions. The fact that K+ activity can be found in late assembly 
intermediates such as V--lysate and U--lysate (Katsura and Kuhl, 1975) also supports the idea 
that it may be loosely associated with the early assembly intermediates. 
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4.6.2 Estimation of the stoichiometries of the tail tip proteins 
Sections 4.2-4.5 show the examination of lambda tail tip proteins (gpI, gpL and gpK) from 
different preparations. There are advantages and disadvantages for each method. The strength of 
the technique using E. coli cells to precipitate lambda tail tip assembly intermediates is that gpJ 
and anything associated with it will be precipitated. This may also be a drawback because the 
stoichiometries of the tail tip assembly intermediates will be distorted due to the over-
representation of proteins added early in the assembly pathway. Another drawback to this 
technique is that the activity of the assembly intermediates can not be determined. In order to 
solve this problem, sucrose gradient centrifugation followed by in vitro complementation and 
Co-IP were performed. The main advantage of this method is that the biological activity of the 
tail assembly intermediates can be examined by an in vitro complementation assay. Like the 
technique using E. coli cells to precipitate assembly intermediates, the stoichiometries of the tail 
tip proteins are distorted in this method. This is because the tail tip and the tail tip assembly 
intermediates have the same sedimentation coefficient and therefore they will sediment to the 
same position in the gradient. This disadvantage also applies to the method using glycerol 
gradient to purify lambda tail. The only method that does not have this problem is the one using 
cesium chloride step gradient to purify lambda phage.  Phages are separated by density not 
sedimentation as in a sucrose or glycerol gradient. Desipte the caveats listed above, the 
approximate consistency among the different methods for the amounts measured for most of the 
proteins suggests that these numbers are likely to be relatively accurate. 
 
Table 4.5 is a summary of the copy numbers of the tail proteins from Tables 4.1, 4.3 and 4.4. The 
lambda tail is thought to be three-fold symmetric and the copy numbers of the tail proteins are  
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Table 4.5 Summary of the copy numbers of tail proteins from different preparations. 
 
The following table is a summary of Tables 4.1, 4.3 and 4.4. The copies of other proteins were 
normalized to 3 copies of gpJ expect for the copies of gpL and gpM in purified phage, which 
were normalized to 6 copies of gpU. 
 pIam pKam6 pLdel pLtail λ tail λ phage 
gpJ 3 3 3 3 3 3 
gpI  3-5 3-4 2-3 1-3  
gpL ~1 2-3  2-4 3-4 ~1 
gpK    <0.6   
gpH     1-3  
gpH*     5-8 6 
gpV     153-177 178 
gpU      6 
gpM      8 
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therefore thought likely to be a multiple of 3 or 6. If this is true, the best estimation of the 
stoichiometries of the tail proteins from my studies is that there are probably 3 copies of gpL and 
3 copies of gpI involved in each tail assembly pathway. The copy number of gpK required for 
the assembly remains unknown due to the fact that it was not detected in the various structures 
examined (except in the case of DnaK, see below) possibly because it may be loosely associated 
with the early assembly intermediates. The absence of gpK in the mature virion is consistent with 
previous studies. So far, it is not clear how many copies of gpL are present in the mature virion. 
The gpL band appears a little fuzzy on SDS-PAGE. The same phenomenon has been observed in 
other sample preparations. In most cases, this seems to happen after the sample has been kept in 
4℃ or -20℃ for several days. But this is not the case for the gpL in the mature virion. The gpL 
band looks a little fuzzy even when the sample is fresh. This may be an artifact of gel 
electrophoresis due to the presence of 8 cysteine residues in gpL. 
 
In addition to gpL, the copy number of gpI in the mature phage remains an open question. We 
know that gpI is required for lambda tail assembly and that it is present in the tail which is not 
attached to the head. No gpI-like band is found in the mature virion. This is not consistent with 
previous studies. One possibility is that the gpI band is not well established in the previous 
experiment. The band observed in the previous studies which is thought to be gpI may be the 
band which migrates a little slower than gpI as I found in the cesium chloride purified phage. 
4.6.3 DnaK and the biologically active assembly intermediates 
Attempts to determine the protein composition and stoichiometry for the biologically active 
assembly intermediates were thwarted by the fact that the position of the sucrose gradients with 
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in vitro complementation activity had almost no detectable amounts of the tail proteins after 
precipitation with antibodies that bring down gpI or gpL. This was unexpected because in 
principle these intermediates are the same as the ones that were precipitated with E. coli cells, 
which had substantial amounts of gpJ, gpI and gpL. Possibly the assembly complexes are 
unstable in the sucrose gradient, which could also explain the long-established fact that the level 
of in vitro complementation from such gradients is extremely low. 
 
A potentially important result from these experiments is that a band identified as DnaK was co-
precipiated by antibodies against immunotags on gpI and gpL. The DnaK detected in this way 
co-migrated on the sucrose gradients with the biological activity of the tail proteins. Although 
pre-immune serum was not available for this commercial antibody for a negative control, the 
DnaK band was not precipitated by the groEL antibody, suggested that the DnaK was indeed 
being precipitated as a result of forming a complex with the immunotagged tail proteins. If this is 
correct, it suggests that DnaK, which has well-established roles in protein folding and assembly / 
disassembly, has a role in production of lambda tails. It is interesting that one protein that co-
precipitates with anti-DnaK antibodies has the mobility of gpK, which has not been seen in any 
of the other attempts to visualize tail assembly complexes. 
 
A puzzling feature of these data is that DnaK is only co-precipitated by the tail tip complex 
separated by sucrose velocity gradient, but not by E. coli cells. One possible interpretation is that 
DnaK is released after attachment of the tail tip complex to E. coli LamB receptors. 
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5.0 CHARACTERIZATION OF THE CYSTEINE RESIDUES IN λ gpL 
5.1 INTRODUCTION 
Many proteins contain cysteine residues, some of which may play a key role in the protein 
folding pathway. In spite of the fact that the reducing environment of the cytoplasm of bacteria is 
generally believed to be unfavorable for disulfide bond formation,  there has been some evidence 
indicating that some cysteines in bacteriophages carry out important roles in protein formation or 
phage assembly. The tailspike protein of Salmonella phage P22, for example, has 8 cysteine 
residues among its 666 amino acids. Although no disulfide bonds have been found in the native 
state of the tailspike protein, there is a transient interchain disulfide bond formation in the 
protrimer intermediates which is required for the correct folding and assembly of the tailspike 
(Sauer et al., 1982; Sargent et al., 1988; Sather and King, 1994; Steinbacher et al., 1994; 
Robinson and King, 1997). Cysteines can have other roles in proteins as well. A common 
example is coordinating metal ions, as in zinc fingers (Berg, 1990). 
 
The λ tail tip protein, gpL, has 8 cysteines among its 232 amino acids. According to multi-
sequence alignments, 4 of them are perfectly conserved among λ gpL homologs (Figure 5.1). 
The conserved cysteine residues may be essential for correct protein folding or tail assembly or 
for functioning of the assembled tail. In order to characterize the cysteine residues, I used  
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Figure 5.1 Multi-sequence alignments of phage λ gpL and its homologs. 
 
Lambda tail tip protein, gpL, contains 8 cysteines among its 232 amino acids. ClustalW2 was 
used to produce multiple sequence alignments among homologous sequences identified by a 
BlastP search. Each protein in the examined group contains 5-8 cysteines. The result shows that 
the cysteine residues at positions 173, 182, 205 and 212 are perfectly conserved among lambda 
gpL and the examined group of its homologs while the cysteine residues at positions 12, 39, 140 
and 208 are non-conserved. The non-conserved cysteine residues are highlighted by red 
rectangles whereas the conserved cysteine residues are highlighted by blue rectangles. On the left 
side of the figure, the word before the underline shows the name of phage whereas the word after 
the underline is the λ gpL homolog in this phage. For instance, ES18_gp26 means that in phage 
ES18, gp26 is a homolog of λ gpL. 
 
ptfc: putative tail fiber component 
mtpL: minor tail protein L 
mtp: minor tail protein 
 
 
 
 
 
 
 
 153
 
 
 
 154
site-directed mutagenesis to mutate individual cysteine residues and then characterized the 
mutant proteins by a series of assays. 
5.2 DETERMINATION OF THE ROLE OF THE CYSTEINE RESIDUES IN λ gpL 
5.2.1 Construction of mutation in gene L 
The pGEX-6p-1-L plasmid encodes gpL with a GST fusion at the N-terminus. This recombinant 
protein functions as well as the wildtype protein in vivo, as judged by the complementation 
experiments shown in Chapter 3. QuikChange site-directed mutagenesis was used to mutate each 
of the individual cysteines to serine (see MATERIALS AND METHODS). Table 5.1 is a brief 
description of the plasmids and the positions of mutations introduced. 
5.2.2 Determination of the biological activity of the mutant proteins in vivo 
Each target plasmid was co-transformed with pLysS into strain BL21(DE3)-Δtail. Spot 
complementation assay was conducted to examine if the mutation has any effect on the activity 
of gpL. Figure 5.2 shows that the C12S, C39S and C208S mutants can complement as well as 
GST-L. Single amino acid substitution at position 140, 173, 182, 205 or 212 abolishes the ability 
of the mutant protein to complement in vivo. According to the multi-sequence alignments, C140 
is not conserved among lambda gpL homologs. Since some of its homologs, which show high 
sequence similarity with lambda gpL, have methionine at the position corresponding to lambda 
gpL C140, site-directed mutagenesis was performed to construct the C140M mutation. The result 
 155
Table 5.1 Description of plasmids and positions of mutation. 
 
All plasmids listed below use pGEX-6p-1 vector which adds a GST fusion at the N-terminus of 
the target protein. The numbering of the cysteine residues is based on their positions in the 
wildtype gpL, not GST-L.  
Plasmid Protein 
pGEX-6p-1-L (pGL) GST-L  
pGEX-6p-1-L1S (pGL1) GST-L with C12S mutation 
pGEX-6p-1-L2S (pGL2) GST-L with C39S mutation 
pGEX-6p-1-L3S (pGL3) GST-L with C140S mutation 
pGEX-6p-1-L4S (pGL4) GST-L with C173S mutation 
pGEX-6p-1-L5S (pGL5) GST-L with C182S mutation 
pGEX-6p-1-L6S (pGL6) GST-L with C205S mutation 
pGEX-6p-1-L7S (pGL7) GST-L with C208S mutation 
pGEX-6p-1-L8S (pGL8) GST-L with C212S mutation 
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Figure 5.2 Determination of the biological activity of the mutant proteins in vivo. 
 
Each target plasmid was co-transformed with pLysS into strain BL21(DE3)-△tail. The spot 
complementation assay was conducted as described previously. Each plasmid was spotted with 
λcI857 and λLam756cI857. The first column shows the plasmid tested and the second column is 
the type of the protein or the position of mutation. The third and fourth columns show the type of 
phage used.  
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from spot complementation assay shows that the C140M mutation has little effect on the 
biological activity of gpL (Figure 5.3 (a)-(c)).  
 
In addition to the single amino acid substitutions, I also constructed a triple mutant with cysteine 
residues at positions 12, 39 and 208 changed to serines, and a quadruple mutant which only 
contains the four conserved cysteines. The triple mutant behaves nearly as well as the wildtype 
protein while there is a ~10-fold decrease in the activity of the quadruple mutant (Figure 5.3 (d)-
(e)). As has been shown in the previous chapters, cysteines in gpL may cause problems during 
purification and it may contribute to the abnormal behavior of gpL on SDS-PAGE. The triple 
mutant, which contains only 5 cysteine residues and can function almost as well as the wildtype 
protein in vivo, may be a good candidate for structural studies. 
5.2.3 Investigation of the conserved cysteine residues in λ gpL 
The previous section shows that the single amino acid substitutions of the conserved cystiene 
residues result in the inability of gpL to complement in vivo. This suggests that these cysteine 
residues are likely to be important for protein folding or tail assembly. There are four different 
steps at which the cysteines may play a role: (1) tail assembly, (2) tail attachment to head, (3) 
phage adsorption to host cells, and (4) DNA injection. In order to find out which step is defective 
in these mutants, the target mutation was introduced into the pEtail4 plasmid and this is followed 
by a series of assays to investigate the role of the conserved cysteine residues in gpL.  
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Figure 5.3 Spot complementation assay to examine the activity of the mutants. 
 
The spot complementation assay was conducted as described previously. The first and second 
columns show the plasmid tested and the protein encoded by the plasmid or the position of 
mutation, respectively. The third and fourth columns show the type of phage used. 
 
(a) pGRX-6p-1: empty vector.  
 
(b) pGEX-6p-1-L (pGL): encodes λ gpL with a GST fusion at the N-terminus.  
 
(c) pGEX-6p-1-L3M (pGL3M): encodes GST-L with C140M mutation.  
 
(d) pGEX-6p-1-L127 (pGL127): encodes GST-L with C12S, C39S and C208S mutations. 
 
(e) pGEX-6p-1-L4C (pGL4C): encodes GST-L with the four non-conserved cysteines mutated 
(C12S, C39S, C140M and C208S).  
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(1) Tail assembly 
One possibility for the inability of the mutants to complement in vivo is that they are unable to 
assemble lambda tail. In order to find out if the conserved cysteine residues are essential for 
lambda tail assembly, the individual cysteine to serine mutations were introduced into the pEtail4 
plasmid which encodes all the 11 proteins required for lambda tail assembly. Lambda tail 
proteins expressed from the plasmid were radiolabeled and prepared for 10-30% glycerol 
gradient (see MATERIALS AND METHODS). About 12 fractions were collected from each 
gradient tube after centrifugation. Figure 5.4 shows that the single amino acid substitution at 
position 173, 182 or 205 disables lambda tail assembly. The C212S mutant, however, is able to 
assemble lambda tails. The gpV band in the fraction which contains most of the purified tail 
from both the wildtype and C212S mutant samples was quantified in the same way as described 
in the previous chapter. Based on the net intensity of the gpV band, the amount of the tail in the 
C212S mutant sample is about 4.2±1.0% of that of the wildtype sample.  
 
(2) Tail attachment to head 
Figure 5.4 shows that a small amount of tail can accumulate in the C212S mutant, but it does not 
tell whether or not the mutant tail is able to attach to lambda head or host cells. In order to 
investigate the ability of the mutant tail to attach to lambda head, radiolabeled tail proteins 
expressed from pEtail or pEtail4-8S were incubated with non-radiolabeled, purified head 
prepared from 594(λVam750S7cI857) lysogen to allow the binding of tail to head. This was 
followed by cesium chloride step gradient to separate phage from other components in the lysate 
(see MATERIALS AND METHODS). The gradient tube was fractionated after centrifugation. If 
the mutant tail is able to bind to the head, mutant phage will be found in about the same fraction  
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Figure 5.4 Effect of single amino acid substitution on lambda tail assembly. 
 
The conserved cysteine to serine mutation was introduced into pEtail4. The plasmid was co-
transformed with pLysS into strain BL21(DE3)-Δtail. λ tail proteins expressed from the plasmid 
were labeled by 35S-Met and prepared for 10-30% glycerol gradient followed by fractionation 
(see MATERIALS AND METHODS). Each fraction was prepared for 15% SDS-PAGE 
followed by autoradiography. The bands representing tail proteins are labeled on the right. For 
Panels (a)-(g), lanes 1-12 are fractions from the bottom to the top of the gradient, and lane 13 is 
the sample used for the gradient. Red rectangles indicate the fraction which contains most of the 
tail. 
 
(a) pEtail4-Lam: an amber mutation was introduced to gene L, resulting in an amber fragment 
with 95 amino acids.  
 
(b) pEtail4: encodes all 11 proteins required for lambda tail assembly.  
 
(c) pEtail4-7S: the non-conserved cysteine at 208 in gpL was mutated to serine.  
 
(d) pEtail4-4S: encodes gpL with C173S mutation.  
 
(e) pEtail4-5S: encodes gpL with C182S mutation.  
 
(f) pEtail4-6S: encodes gpL with C205S mutation.  
 
(g) pEtail4-8S: encodes gpL with C212S mutation.  
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as the wildtype phage. Figure 5.5 shows that a small amount of mutant phage was found in about 
the same position as the wildtype phage. By using the same quantification method as described 
above, it was found that there is about 5.0±1.2% of the mutant phage compared to the wildtype 
phage in the fifth fraction. This suggests that the mutant tail can attach to head as efficiently as 
the wildtype tail. 
 
In addition, I used the plaque assay to determine the viable phage titer in the fifth fraction from 
both the wildtype and mutant sample. The result shows that the viable phage titer in the mutant 
sample is only about 0.08±0.05% to that of the wildtype phage. Thus the specific infectivity of 
the phage particles with mutant tails is ~1.6% of that of the wildtype particles. This indicates that 
the mutant phage is probably defective in phage attachment to cell envelope or DNA injection. 
 
(3) Phage adsorption to host cells 
In order to find out if the C212S mutant phage is able to attach to E. coli cells, I used E. coli cells 
to precipitate lambda tail. If the mutant tail is able to bind to LamB receptor, it will be 
precipitated by E. coli cells. Lambda tail proteins expressed from the pEtail4 or pEtail4-8S 
plasmid were radiolabeled and prepared for incubation with E. coli cells as described previously. 
Figure 5.6 shows that the mutant tail can attach to host cells. Based on the net intensity of the 
gpV band in the wildtype and C212S mutant samples, the amount of mutant tail bound to 
bacteria is about 4.3±0.6% to that of the wildtype tail. This suggests that the mutant tail can 
adsorb to bacteria as efficiently as the wildtype tail. Taken together, the results from the above 
experiments imply that the C212S mutant is probably defective in DNA injection.  
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Figure 5.5 The mutant tail is as efficient as the wildtype tail in attachment to λ head. 
 
λ tail proteins expressed from pEtail4 or pEtail4-8S were radiolabeled by 35S-Met and lysed as 
described (see MATERIALS AND METHODS). The 594(λVam750Sam7cI857) lysogen was 
used for head preparation. The radiolabeled tail lysate was incubated with non-radiolabeled head 
to allow the binding of tail to head. Subsequently, the mixture was loaded onto cesium chloride 
step gradient to purify phage. About 11 fractions were collected from the bottom of the tube. 
Each fraction was prepared for 15% SDS-PAGE followed by autoradiography. In Panels (a) and 
(b), lanes 1-11 are fractions from the bottom to about 1/3 of the gradient tube. The bands 
representing tail proteins are labeled on the right. 
 
(a) The pEtail4 plasmid which encodes all 11 proteins required for lambda tail assembly is used 
for tail preparation.  
 
(b) The pEtail4-8S plasmid differs in pEtail4 in that it encodes gpL with C212S mutation.  
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Figure 5.6 The mutant tail can attach to host cells as efficiently as the wildtype tail. 
 
Tail proteins expressed from the target plasmids were radiolabeled and lysed as described 
previously. The radiolabeled tail lysate was incubated with E. coli cells to allow the binding of 
tail fiber to E. coli cells. Subsequently, the mixture was washed and prepared for 15% SDS-
PAGE. The bands were visualized by autoradiography. Bands representing lambda tail proteins 
are labeled on the right. 
 
Lane 1: pEtail4-Lam: An amber mutation was introduced to gene L.  
 
Lane 2: pEtail4: encodes all 11 proteins required for lambda tail assembly.  
 
Lane 3: pEtail4-7S: differs in pEtail4 in that it encodes gpL with the nonconserved cysteine 
residue at position 208 substituted by serine.  
 
Lane 4: pEtail4-8S: differs in pEtail4 in that it encodes gpL with C212S mutation. The weak 
gpH* band is not a feature of this mutant since this band can be seen clearly when I repeated the 
experiment. 
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5.3 FURTHER CHARACTERIZATION OF C212 OF λ gpL 
In addition to my results, the results from Dr. Davidson’s lab at the University of Toronto 
indicate that gpL binds to a metal, possibly iron (personal communication). It is suggested that 
the conserved cysteine residues in gpL may form an iron-sulfur cluster, which may be important 
for the correct folding of gpL or for the formation of the tail tip. If this is true, it is possible that 
substitution of C212 by histidine may not completely abolish tail assembly since histidines can 
sometimes form zinc rings. In order to further characterize C212, two more mutants, C212A and 
C212H, were constructed into pEtail4 by recombinant PCR. After construction of plasmids, a 
spot complementation assay was performed to determine the biological activity of the mutant. 
Figure 5.7 shows that λLam756cI857 can grow on any of the mutants tested at ~0.1% efficiency. 
Since the mutant protein encoded by pEtail4-6S is defective in tail assembly, it is likely that this 
level of phage growth is due to recombination between two alleles to give a wildtype sequence. 
 
The C212A and C212H mutants were then examined by glycerol gradient for their ability to 
assemble λ tails as described previously. Figure 5.8 shows that the majority of the wildtype tail is 
found in the eighth and ninth fractions whereas no tail-like structures are present in these 
fractions in either mutant. Therefore, neither of the mutants is able to assemble tails. I also tried 
to find out if there is any difference in the early tail assembly intermediates for the C212A, 
C212H and C212S mutants. Each mutation was introduced to the pGtail plasmid, which encodes 
the first eight proteins involved in lambda tail assembly. E. coli cells were used to precipitate 
lambda tail assembly intermediates. Surprisingly, the C212A and C212H mutants behave like the 
wildtype protein while there is a significant decrease in the amount of the tail tip proteins  
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Figure 5.7 Spot complementation test to determine the biological activity of C212A and C212H 
mutants. Each plasmid was co-transformed with pLysS into BL21(DE3)-△tail. The spot 
complementation experiment was performed as described previously. Each target plasmid was 
tested for its ability to complement λLam756cI857 (L756). No IPTG or 1 mM IPTG was present 
in the top soft agar. 
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Figure 5.8 Separation of λ tail by glycerol gradient. 
 
The radiolabeled tail lysates were prepared and loaded onto 10-30% glycerol gradient as 
described previously. After centrifugation, each gradient was punctured at the bottom and about 
13 fractions were collected. Each fraction was prepared for 15% SDS-PAGE followed by 
autoradiography. In Panels (a)-(c), lanes 1-13 are fractions 1-13 from the bottom to the top of the 
gradient. 
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precipitated by E. coli cells in the C212S mutant (Figure 5.9). Since the C212S mutant lysate can 
accumulate a small amount of tail as shown in the previous sections, the result suggests that in 
the absence of the other tail proteins, the tail assembly intermediates produced by pGtail with 
C212S mutation may be not as stable as that from the wildtype protein. In addition, the result 
suggests that the C212A and C212H mutants may be defective in some late steps in the tail 
assembly pathway. So far, it remains an open question for why the conserved cysteine to serine 
substitution causes problems in the tail assembly. To answer this question, it is probably essential 
to study the structure of gpL.  
5.4 DISCUSSION 
Sections 5.2-5.3 describe the investigation of the cysteine residues in the lambda tail protein, gpL. 
A summary of the results for the cysteine mutants is shown in Figure 5.10. The result from the 
complementation assay shows that the single amino acid substitution at position 12, 39, 140 or 
208 has little effect on the biological activity of the protein whereas the single amino acid 
substitution at position 173, 182, 205 or 212 results in the inability of the protein to complement 
in vivo. This result is consistent with the multi-sequence alignments. In addition, the result also 
suggests that the conserved cysteine residues may be important for protein folding or tail 
assembly or for the functioning of the assembled tail or metal binding. 
 
In order to further characterize the conserved cysteine residues, the individual mutation was 
introduced into pEtail4. The radiolabeled tail lysate was first examined by glycerol gradient. 
Figure 5.4 shows that the single amino acid substitution at position 173, 182 or 205 completely 
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Figure 5.9 Precipitation of λ tail assembly intermediates by E. coli cells. 
 
The tail proteins expressed from the target plasmid were radiolabeled and mixed with E. coli 
cells as described previously. Each sample was incubated with Ymel (an E. coli K12 strain with 
LamB receptor) and CR63 (an E. coli strain which carries a point mutation in gene lamb and 
therefore is resistant to lambda phage).  Lambda tail tip proteins are labeled on the right.  
 
Lanes 1-2: pGtail: encodes the first eight proteins involved in lambda tail assembly. The lysate 
was precipitated by Ymel (lane 1) or CR63 (lane 2). 
 
Lanes 3-4: pGtail-8A: differs in pGtail in that it encodes gpL with C212A mutation. The lysate 
was precipitated by Ymel (lane 3) or CR63 (lane 4). 
 
Lanes 5-6: pGtail-8H: differs in pGtail in that it encodes gpL with C212H mutation. The lysate 
was precipitated by Ymel (lane 5) or CR63 (lane 6). 
 
Lanes 7-8: pGtail-8S: differs in pGtail in that it encodes gpL with C212S mutation. The lysate 
was precipitated by Ymel (lane 7) or CR63 (lane 8). 
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Figure 5.10 Summary of the cysteine mutants in λ gpL. 
 
This is a summary of the results for the cysteine mutants in lambda gpL from Sections 5.2-5.3. 
 
(a) The positions of the cysteine residues in protein gpL are shown. Whether or not the cysteine 
residues are conserved is based on the multi-sequence alignments shown in Figure 5.1. 
 
(b) A summary of the phonotypes for the cysteine mutants is shown. The triple mutant contains 
C12S, C39S and C208S mutations whereas the quadruple mutant contains C12S, C39S, 140M 
and C208S mutations.  
 
+: the number of complementation phage titers is at least 1000 fold over the background phage 
-: the complementation phage titer is about the same as the backround phage titer 
N/A: the mutant has not been examined 
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abolishes lambda tail assembly. A small amount of tail can accumulate in the C212S mutant 
lysate. Further characterization of this mutant indicates that the mutant tail is as efficient as the 
wildtype tail in binding to head and attachment to host cells. Taken together, these results show 
that all of the mutants that have a change in a conserved cysteine are defective in tail assembly, 
and that the small number of tails successfully assembled by the C212S mutant are defective in a 
step of infection following adsorption to the cell. These experiments therefore identify two 
different steps in tail assembly and function where gpL has an essential role. 
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6.0 CHARACTERIZATION OF λ gpK 
6.1 INTRODUCTION 
The lambda gene K encodes a 199 amino acid protein. Its gene product, gpK, is required for tail 
assembly, but it is not detected in the mature virion. In previous studies, a phage with an amber 
mutation in gene K (λKam768Sam7cI857) was isolated (Parkinson, 1968). The lysate made from 
this mutant phage can accumulate some phage-like particles which sediment as fast as normal 
phages (Katsura and Kuhl, 1975). These K- phages are not infective by themselves, but they can 
complement all other tail-defective lysates except the K--lysate (Katsura and Kuhl, 1975). These 
results suggest that  gpK can be bypassed to some extent (Katsura and Kuhl, 1975). However, it 
is also possible that the amber fragment of gpK is sufficient to rescue the formation of a small 
fraction of phage-like particles.  
 
In order to further characterize gpK, the gene K in λKam768Sam7cI857 phage was sequenced to 
identify the position of the amber mutation. The result shows that this mutant phage encodes a 
167-amino-acid amber fragment. Another amber mutation, Kam6, was introduced early in gene 
K. These two amber mutants were further characterized by in vivo and in vitro assays.  
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6.2 CONSTRUCTION AND CHARACTERIZATION OF AMBER MUTATIONS 
IN λ GENE K 
6.2.1 Construction of amber mutations in λ gene K 
The pEtail4 plasmid encodes all 11 proteins required for lambda tail assembly. Two different 
amber mutations were constructed into this plasmid, resulting in pEtail4-Kam6 and pEtail4-
Kam768. These two plasmids differ from pEtail4 in that they carry an amber mutation early in 
gene K (pEtail4-Kam6) or late in gene K (pEtail4-Kam768). 
 
An amber mutation in the sixth codon of gene K was constructed by recombinant PCR in 
plasmid pLtail, to give plasmid pKam6 (Table 3.1). Plasmid pEtail4-Kam6 was constructed by 
inserting the BsrGI-RsrII fragment of pKam6 into the BsrGI-RsrII sites of pEtail4.  
 
The amber mutation in pEtail4-Kam768 is the same amber mutation in gene K as in the 
previously isolated mutant phage λKam768Sam7cI857. PCR was performed to amplify gene K 
in this mutant phage. Subsequently, the PCR product was sequenced to identify the position of 
the amber mutation. The sequence result shows that the introduction of Kam768 mutation should 
result in a 167-amino-acid amber fragment (data not shown). Subsequently, recombinant PCR 
was performed to introduce the Kam768 mutation into pEtail4 to construct the pEtail4-Kam768 
plasmid (see MATERIALS AND METHODS). 
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6.2.2 Determination of the biological activity of the amber fragments in vivo 
After construction of plasmids, a spot complementation assay was carried out to determine the 
ability of the amber fragment to complement λKam768cI857 in vivo. The experiment was 
performed as described previously and the result is shown in Figure 6.1. The wildtype phage, 
λcI857, grows equally well on all the strains tested, demonstrating that neither K amber fragment 
interferes with phage growth at the low level of expression tested. No complementation activity 
is found between pEtail4-Kam768 and λKam768cI857 as expected since they contain the same 
amber mutation in gene K. Phage λKam768cI857 does make plaques on the strain carrying 
pEtail4-Kam6 at about 1% efficiency. I ascribe this not to complementation but to recombination 
between Kam6 and Kam768, as mentioned in Chapter 3. 
6.2.3 Characterization of the amber mutants in vitro 
(1) Glycerol gradient 
The in vivo complementation assay shows that both of the amber fragments have little biological 
activity. However, it does not tell which step is affected by the mutation. In order to further 
characterize these amber mutants, glycerol gradient was performed to examine if there is any tail 
formation in the lysate containing the amber fragment. The experiment was carried out as 
described previously. Figure 6.2 shows that no tail is found in the lysate made from pEtail4-
Kam6 (Panel b). However, a small amount of tail-like structure is accumulated in the lysate 
made from pEtail4-Kam768 (Panel c). The comparison of the band intensity of gpV reveals that 
the assembly efficiency of the mutant protein is about 3.1±0.9% to that of the wildtype protein. 
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Figure 6.1 Determination of the biological activity of the amber fragments in vivo. 
 
Each target plasmid was co-transformed with pLysS into BL21(DE3)-Δtail. The spot 
complementation experiment was carried out as described previously. The plasmids of interest 
were tested for their ability to complement λKam768cI857 (K768). The wildtype phage, λcI857 
(cI857), was used as a positive control. No IPTG or 1 mM IPTG was added to the top soft agar. 
The presence or absence of IPTG makes no difference for the growth of λcI857 on the strains 
carrying the target plasmids. Therefore, only the result without IPTG in the top soft agar is 
shown here. 
 
(a) Each target plasmid was tested for its ability to complement λKam768cI857 (K768). 
 
(b) The strains with the target plasmids were spotted with λcI857 (cI857). 
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Figure 6.2 Separation of λ tail by glycerol gradient. 
 
BL21(DE3)-△tail was used as the host strain. The tail proteins expressed from the target 
plasmid were radiolabeled by 35S-Met and prepared for 10-30% glycerol gradient as described in 
MATERIALS AND METHODS. After centrifugation, each gradient tube was collected into 
about 12 fractions. Each fraction was prepared for 15% SDS-PAGE followed by 
autoradiography. Lanes 1-12 in Panels (a)-(c) are fractions 1-12 from the bottom to the top of the 
gradient. Lane 13 is the sample used for the gradient. 
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(2) Cesium chloride step gradient 
Next, I want to examine if the tail made from pEtail4-Kam768 is able to attach to lambda head. 
The experiment was carried out as described previously and the result is shown in Figure 6.3. 
The mutant tail is able to attach to head. Based on the net band intensity of gpV, the amount of 
the mutant phage is approximately 3.6 ±1.1% of the wildtype phage. This suggests that the 
mutant tail can attach to the head as efficiently as for the wildtype phage. 
6.3 DISCUSSION 
The function of gpK is a mystery because it is required for lambda tail assembly, but it is not 
detected in the mature tail structure. One possible interpretation of this observation is that it may 
play a chaperone-like role. Based on the result from PSI-BLAST, the protein sequence of gpK 
matches many cell wall-associated hydrolases and NLP/P60 family proteins, a family of cell-
wall peptidases. All characterized members of this family have been shown to either hydrolyze 
D-glutamyl-meso-diaminopimelate or N-acetylmuramate-L-alanine linkages (Anantharaman and 
Aravind, 2003). Many phages contain a protein with lysozyme activity (Moak and Molineux, 
2004). Gp5 of bacteriophage T4, for example, has lysozyme activity and helps the tail tube 
penetrate through the cell envelope during infection (Kanamaru et al., 2002). It is therefore 
tempting to speculate that gpK could be a lysozyme in the λ tail. Arguing against this possibility 
is the failure to detect a band corresponding to gpK in SDS gels of λ virions. However, I cannot 
rule out the possibility that gpK is proteolytically processed during tail maturation and the 
fragment or fragments that remain in the virion have not been detected. 
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Figure 6.3 Separation of lambda phage by cesium chloride step gradient. 
 
594(λVam750Sam7cI857) was used for head preparation (see MATERIALS AND METHODS). 
Lambda tail proteins expressed from the target plasmid were radiolabeled by 35S-Met as 
described in MATERIALS AND METHODS. The non-radiolabeled head was incubated with 
radiolabeled tail to allow the binding of head to tail (see MATERIALS AND METHODS). 
Subsequently, the mixture was loaded onto a cesium chloride step gradient. After centrifugation, 
the tube was punctured at the bottom and about 12 fractions were collected. Each sample was 
prepared for 15% SDS-PAGE and visualized by autoradiography. In Panels (a) and (b), lanes 1-
12 were fractions 1-12 from the bottom to about 1/3 of the gradient tube. 
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My experiments suggest that a small amount of phage-like particles can accumulate in the 
Kam768 lysate. This result is consistent with previous studies about this mutant (Katsura and 
Kuhl, 1975). In addition, my result shows that the Kam6 is unable to assemble lambda tail. 
Taken together, these results argue that gpK is required for assembly of tails but that the 167-
amino-acid amber fragment of Kam768 does support assembly of tail-like structures of 
approximately normal size and composition, which are able to attach to heads (Katsura and Kuhl, 
1975). However, these tails are not functional unless they are complemented with a lysate 
capable of supplying wildtype gpK. Thus, it appears that gpK has at least two discernable 
functions. The first is to assist tail assembly. This function can be carried out, albeit inefficiently, 
by a gpK lacking the last 32 amino acids. The second function, which requires that the rest of the 
gpK sequence be present, makes the assembled virion capable of infecting. This could mean that 
gpK is present in the mature virion, acting, for example, as a lysozyme to make a hole in the cell 
wall for DNA injection. Alternatively, it could mean that gpK modifies the propertities of the tail 
during assembly to make it competent to support infection, and may or may not itself be present 
in the mature tail. 
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7.0 DISCUSSION 
7.1 CHANGES ON ATTACHMENT TO THE HOST CELL 
The result of the experiment using E. coli cells to precipitate lambda tail tip assembly 
intermediates (Figure 4.1) shows that a mystery band, xx2, is only present in the pLtail lane. 
Therefore, it is likely that band xx2 is a processed or degradation product of one of the tail tip 
proteins. The presence of this band may be explained by the possibility of the change in the tail 
tip complex upon attachment to the host cell. That is upon attachment to the host cell, the tail tip 
may undergo certain change which may result in one of the tail tip proteins to be proteolytically 
degraded or processed and this change may only happen in the tail tip complex, but not in the tail 
tip assembly intermediates. Since the relative amount of gpI in the pLtail lane seems less than 
that in the pLdel or pKam6 lane, it is possible that band xx2 may be a processed or degradation 
product of gpI. 
7.2 DnaK MAY BE REQUIRED FOR THE TAIL TIP COMPLEX TO BE 
BIOLOGICALLY ACTIVE 
The results from the separation of lambda tail tip complex by the sucrose velocity gradient 
followed by in vitro complementation assay and Co-IP (Figures 4.4, 4.5 and 4.7) show that the 
 193
fraction which has most in vitro complementation activity contains very small amounts of the 
lambda tail tip proteins. In contrast, the majority of the tail tip proteins are present in the top 
fractions from the gradient and they are not biologically active. One possible explanation is that 
DnaK may be required for the tail tip complex to be biologically active, since DnaK is present in 
the fraction which has most in vitro complementation activity, but not in the top fractions. 
Arguing against this possibility is the absence of DnaK in the tail tip complex precipitated by E. 
coli cells (Figure 4.1). However, this can be explained by that DnaK may be released upon 
attachment of the tail fiber to the cell envelope. 
7.3 gpK MAY BE A LYSOZYME 
Based on the result from PSI-BLAST, the sequence of gpK matches many cell wall-associated 
hydrolases and the NLP/P60 family proteins. This leads to the assumption that gpK may be a 
lysozyme. The results from my experiments about Kam6 and Kam768, suggest that the function 
of gene K can not be bypassed. The results about Kam768 mutation from my experiments are 
consistent from previous studies (Katsura and Kuhl, 1975). Besides, previous studies also show 
that the Kam768 mutant phage has little infectivity. However, when it is complemented by other 
tail-defective lysates, the mutant phage will become infectious. Taken together, these data 
suggest that gpK may be a lysozyme and may help facilitate penetration of the cell wall during 
infection. The fact that the gpK band is not detected in the mature tail purified by glycerol 
gradient and in the phage purified by cesium chloride step gradient may argue the possibility of 
gpK to be a lysozyme. However, in both purified mature tail and lambda phage, there is a band 
which migrates a little faster than gpK (band xx4 in Figure 4.9 and band xx5 in Figure 4.10). It is 
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possible that gpK may need to be processed during tail assembly and this band may be a 
processed form of gpK. If this is true, it may not be surprising since the lambda tape measure 
protein, gpH, has been shown to be processed during assembly in order to form a biologically 
active tail (Murialdo and Siminovitch, 1972; Tsui and Hendrix, 1983). 
7.4 COMPOSITION AND STOICHIOMETRY OF THE TAIL TIP COMPLEX 
The result from precipitation of the tail tip complex by E. coli cells shows that gpJ, gpI and gpL 
are present in the tail tip complex (Figure 4.1). The presence of gpK in the complex is not clear 
from this experiment. However, the fact that gpK is co-precipitated with DnaK in a sucrose 
velocity gradient indicates that gpK is present in the tail tip complex (Figure 4.8). The presence 
of gpK in the tail tip complex is consistent with previous in vitro complementation data which 
show that gpK activity is found in a complex late in the tail assembly pathway (Katsura and Kuhl, 
1975). One possible explanation for the absence of gpK in the tail tip complex precipitated by E. 
coli cells is that upon attachment to the host cell, the tail tip complex may undergo some change 
which may result in gpK to be proteolytically degraded or processed. Another possibility is that 
gpK may be loosely associated under the experimental conditions. 
 
The quantification results from several different methods suggest that there may be three copies 
of gpI and three copies of gpL involved in the tail assembly pathway. The copy numbers of gpK 
involved in the tail assembly pathway is unknown since gpK is not detectable in most 
experiments.  
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